https://www.reumatizam.abol.hr/ daily 1.0 https://www.reumatizam.abol.hr/latest daily 0.9 https://www.reumatizam.abol.hr/archive weekly 0.9 https://www.reumatizam.abol.hr/supplements monthly 0.7 https://www.reumatizam.abol.hr/about 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/ownership-and-governance 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/editorial-board 2026-07-16 monthly 0.6 https://www.reumatizam.abol.hr/reumatizam-book 2026-07-16 monthly 0.6 https://www.reumatizam.abol.hr/impressum 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/contact 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/publication-ethics 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/instructions-for-authors 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/declarations-and-forms 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/author-fees 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/copyright 2026-07-18 monthly 0.6 https://www.reumatizam.abol.hr/issues/47/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2025/supplement-1/reumatizam-72-supplement-1-2025.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/46/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/45/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/44/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/43/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/42/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/41/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/40/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2022/1/reumatizam-69-1-2022.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/38/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/39/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2021/2/reumatizam-68-2-2021.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/37/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2021/1/reumatizam-68-1-2021.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/36/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/35/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2020/2/reumatizam-67-2-2020.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/34/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/33/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2020/1/reumatizam-67-1-2020.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/52/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/32/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2019/2/reumatizam-66-2-2019.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/31/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2019/1/reumatizam-66-1-2019.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/51/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/30/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/media/journals/reumatizam/issues/2018/2/reumatizam-65-2-2018.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/issues/29/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/50/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/28/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/27/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/49/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/26/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/25/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/48/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/24/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/23/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/22/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/21/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/20/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/19/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/18/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/17/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/16/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/15/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/14/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/13/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/12/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/11/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/10/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/9/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/8/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/7/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/6/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/5/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/4/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/3/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/2/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/issues/1/ 2026-07-17 monthly 0.7 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/sjogrens-syndrome-evaluation-of-diagnosis-and-therapy-in-the-light-of-artificial-intelligence-and-transhumanism-quo-vadis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-887.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/chronic-inflammation-and-the-cardiovascular-system/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-888.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/pericarditis-in-systemic-autoimmune-and-autoinflammatory-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-889.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/myocarditis-in-systemic-autoimmune-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-890.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/venous-thromboembolism-and-the-antiphospholipid-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-891.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/pulmonary-arterial-hypertension-in-inflammatory-rheumatic-and-systemic-autoimmune-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-892.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/heart-failure-in-patients-with-inflammatory-rheumatic-and-systemic-autoimmune-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-893.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/the-role-of-cardiac-imaging-in-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-894.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/cardiac-arrhythmias-in-patients-with-autoimmune-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-895.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/assessment-of-the-cardiovascular-risk-in-patients-with-systemic-autoimmune-disease-with-a-focus-on-systemic-lupus-erythematosus-and-the-score-2-assessment-tool/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-896.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/conventional-and-biological-disease-modifying-antirheumatic-drugs-and-cardiovascular-risk/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-897.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/from-inflammation-to-perception-how-does-fibromyalgia-fit-into-the-story-of-pain-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-898.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/role-of-multimodal-analgesia-in-pain-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-899.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/exercise-and-rheumatic-diseases-to-exercise-or-not/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-900.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/when-pain-becomes-an-everyday-thing-the-story-behind-the-smile/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-901.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/difficult-to-treat-psorijaticni-artritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-902.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/preporuke-eular-a-iz-2025-godine-za-lijecenje-sle-a-sa-zahvacanjem-bubrega-pregled-i-primjena-u-primjerima-iz-svakodnevnog-rada/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-903.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/kako-postici-najbolji-ucinak-primjenom-temeljnih-antireumatika/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-904.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/reumatoloska-sekcija-uems-a-uloga-u-izobrazbi-i-specijalistickom-usavrsavanju/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-905.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/implementacija-medicinske-izobrazbe-temeljene-na-kompetencijama-u-standarde-europskih-specijalistickih-programa/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-906.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/uloga-eula-r-a-u-podrzavanju-izobrazbe/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-907.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/a-four-year-follow-up-study-of-cardiovasc-ular-outcomes-in-pa-tients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-908.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/ucestalost-kardiovaskularnih-rizicnih-cimbenika-u-bolesnika-sa-psorijaticnim-artritisom-presjecno-istrazivanje/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-909.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/periodic-prevalence-and-features-of-pulmonary-arterial-hypertension-pah-in-a-retrospective-outpatient-cohort-of-patients-with-inflammatory-rheumatic-diseases-in-the-division-of-clinical-immunology-and/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-910.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/jak-inhibitors-in-patients-with-high-cardiovascular-risk-pro-et-contra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-911.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/asas-class-ification-criteria-for-axial-spondyloarthritis-2025/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-912.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/reduced-bone-mineral-density-is-associated-with-subclinical-atherosclerosis-in-asymptomatic-non-diabetic-postmenopausal-women/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-913.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/treatment-of-syst-emic-lupus-erythematosus-with-anifrolumab-single-centre-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-914.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/estimated-incidence-and-prevalence-of-systemic-lupus-erythematosus-in-croatia-based-on-available-public-health-data/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-915.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/cardiovascular-manifestations-of-sarcoidosis-results-of-research-in-the-republic-of-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-916.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/severe-skin-involvement-nephritis-and-serum-calprotectin-as-predictors-of-relapse-in-childhood-iga-vasculitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-917.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/association-of-gene-markers-of-atherogenesis-mthfr-c677t-and-ppar-pro12ala-with-metabolic-syndrome-and-cardiovascular-risk-in-sjogrens-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-918.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/comparison-of-acreular-classification-criteria-with-diagnostic-criteria-for-chronic-nonbacterial-osteomyelitis-in-children/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-919.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/association-of-physical-activity-and-quality-of-life-depending-on-disease-activity-in-patients-with-axial-spondyloarthritis-a-single-tertiary-center-evaluation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-920.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/prevalence-of-pathological-ancle-brachial-indeks-and-pulse-wave-velocity-values-in-patients-with-rheumatoid-arthritis-and-their-association-with-cardiovascular-risk-factors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-921.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/umjetna-inteligencija-u-reumatologiji-u-2025-godini-modeli-za-istrazivanje-i-klinicku-praksu/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-922.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/cardiovascular-events-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-923.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/major-adverse-cardiovascular-events-in-patients-treated-with-janus-kinase-inhibitors-data-from-our-center/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-924.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/serum-urate-concentration-increases-aortic-stiffness-in-patients-with-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-925.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/atherosclerotic-complications-and-disease-activity-in-children-and-adolescents-with-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-926.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/prevalence-of-atrial-fibrillation-in-patients-with-rheumatoid-arthritis-in-sp-lit-dalmatia-county-experiences-of-a-tertiary-center/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-927.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/vexas-syndrome-a-new-disease-on-the-rheumatologic-horizon/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-928.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/myocarditis-a-rare-manifestation-of-systemic-autoimmune-diseases-a-series-of-patients-hospitalized-at-the-university-hospital-center-zagreb-over-a-ten-year-period/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-929.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/isolated-igg4-related-middle-ear-disease-in-a-young-patient-a-report-of-rare-localization-and-therapeutic-response/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-930.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/the-role-of-serum-calprotectin-as-a-biomarker-of-acute-inflammation-a-pilot-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-931.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/zasto-su-nam-potrebni-registri-pacijenata-u-znanosti-osobno-iskustvo/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-932.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/increased-activity-of-spondyloarthritis-is-associated-with-reduced-serum-vitamin-d-concentration/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-933.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/aortic-regurgitation-in-a-patient-with-rheumatoid-arthritissystemic-lupus-erythematosus-overlap-syndrome-rhupus-case-report-and-review-of-literature/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-934.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/is-there-a-connection-between-disease-activity-and-functional-capacity-with-vdr-polymorphism-in-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-935.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/application-of-the-slerpi-scoring-system-as-class-ification-criteria-for-systemic-lupus-erythematosus-and-its-predictive-value-for-diseas-e-recognition/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-936.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/therapeutic-plasma-exchange-tpe-and-intravenous-immunoglobulins-ivig-in-the-treatment-of-neurological-manifestations-of-vasculitis-in-the-context-of-rheumatoid-arthritis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-937.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/from-suspected-igg4-rd-to-erdheim-chester-disease-the-challenge-of-a-rare-differential-diagnosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-938.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/recurrent-perimyocarditis-treated-with-intravenous-immunoglobulins-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-939.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/serum-calprotectin-differentiates-ac-tive-and-remission-phases-in-childhood-inflammatory-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-940.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/recurrent-pericarditis-a-diagnostic-puzzle/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-941.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/pulmonary-arterial-hypertension-and-sjogrens-disease-report-of-two-patients-and-literature-review/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-942.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/vitamin-d-deficiency-in-inflammatory-arthritis-myth-or-reality/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-943.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/pregnancy-outcomes-in-sle-patients-in-uhc-spl-it/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-944.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/cardiac-manifestations-in-eosinophilic-granulomatosis-with-polyangiitis-patient-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-945.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/dynamics-trends-and-load-profile-of-the-outpatient-clinic-of-the-department-of-clinical-immunology-and-rheumatology-department-for-internal-medicine-uhc-zagreb-for-rheumatology-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-946.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/heterogeneity-of-thrombotic-microangiopathies-in-systemic-connective-tissue-diseases-presentation-of-two-clinical-cases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-947.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/association-of-myositis-specific-antibodies-with-interstitial-lung-disease-in-idiopathic-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-948.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/physicians-awareness-of-cardiovascular-risk-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-949.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/rijetka-orbitalna-prezentacija-p-anca-vezanog-vaskulitisa-uspjesno-lijecena-rituksimabom-i-metotreksatom/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-950.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/recurrent-breast-abscesses-a-rare-manifestation-of-granulomatosis-with-polyangiitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-951.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/myocarditis-in-sle-a-diagnostic-and-therapeutic-challenge/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-952.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/psoriatic-arthritis-and-sarcopenia-preliminary-results-of-a-cross-sectional-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-953.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/the-association-between-tenosynovitis-and-hyperlipidemia-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-954.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/congenital-heart-block-in-one-twin-associated-with-maternal-ss-a-antibodies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-955.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/balneotherapy-compared-to-additional-thermotherapy-in-the-treatment-of-chronic-nonspecific-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-956.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/significance-of-asymptomatic-intracapsular-temporomandibular-disorders-in-patients-with-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-957.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/lumbosacral-plexitis-and-crps-as-atypical-manifestations-of-mpo-anca-positive-vasculitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-958.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/primjena-rituksimaba-u-bolesnika-s-nediferenciranom-bolescu-vezivnog-tkiva-i-autoimunim-hepatitisom-prikaz-slucaja/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-959.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/cervical-ankylosis-as-or-dish/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-960.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/adropin-a-regulatory-peptide-in-autoimmune-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-961.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/multidisciplinary-team-in-the-treatment-of-systemic-lupus-erythematosus-a-patient-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-962.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/meusobni-odnos-psorijaticnog-artritisa-i-aterosklerotske-vaskularne-bolesti-kod-starijeg-muskarca-analiza-na-temelju-slucaja/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-963.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/znanje-hrvatskih-bolesnika-sa-sistemskim-eritemskim-lupusom-o-njihovoj-bolesti-temeljem-upitnika-slake-systemic-lupus-assessment-tool-for-essential-knowledge/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-964.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/a-rare-case-of-polymyositis-and-systemic-sclerosis-overlap-syndrome-with-high-troponin-levels-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-965.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/aseptic-meningitis-as-a-manifestation-of-adult-onset-stills-disease-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-966.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/cardiovascular-and-pulmonary-symptoms-in-ankylosing-spondylitis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-967.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/systemic-sclerosis-occurring-in-a-patient-with-malignant-melanoma-treated-with-nivolumab-a-paraneoplastic-manifestation-or-a-side-effect-of-immunotherapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-968.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/therapeutic-challenges-in-patients-with-cvid-glild-and-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-969.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/symptomatic-dilated-cardiomyopathy-as-an-extraskeletal-manifestation-of-ankylosing-spondylitis-triggered-by-co-vid-19-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-970.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/mpo-anca-interstitial-lung-disease-pa-tient-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-971.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/metastases-or-interstitial-lung-disease-in-antisynthetase-syndrome-patient-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-972.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/myocarditis-myositis-myasthenia-gravis-overlap-syndrome-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-973.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/bosentan-induced-refractory-hypervolemia-in-patients-with-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-974.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/paraneoplastic-raynauds-phenomenon-in-a-patient-with-uveal-melanoma-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-975.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/cutaneous-lesions-as-clinical-manifestation-of-dirofilariosis-in-humans-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-976.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/nintedanib-beyond-the-lungs-a-case-report-of-systemic-sclerosis-with-predominant-gastrointestinal-involvement/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-977.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/livedoid-vasculopathy-in-a-patient-with-a-history-of-covid-19-infection-during-pregnancy-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-978.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/childhood-onset-mixed-connective-tissue-disease-clinical-case-presentations/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-979.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/endocarditis-in-a-patient-with-adult-onset-stills-disease-and-mas-syndrome-a-causal-factor-or-an-associated-complication/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-980.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/acute-parvovirus-b19-infection-as-a-potential-trigger-for-nxp2-positive-idiopathic-inflammatory-myopathy-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-981.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/an-uncommon-age-common-challenges-a-rare-manifestation-of-an-autoinflammatory-disorder/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-982.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/extranodal-cd20-positive-b-cell-non-hodgkins-lymphoma-of-the-gastric-malt-type-in-a-patient-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-983.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/panuveitis-as-a-manifestation-of-granulomatosis-with-polyangiitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-984.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/bilateral-avascular-necrosis-of-hip-and-shoulder-joints-in-patient-after-allogeneic-hematopoietic-stem-cell-transplantation-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-985.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/chronic-graft-vs-host-disease-cgvhd-as-a-late-complication-in-patient-after-hematopoietic-stem-cell-transplantation-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-986.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/procjena-kognitivnih-funkcija-u-bolesnika-sa-psorijaticnim-artritisom/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-987.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/lumbosacral-plexitis-as-the-initial-presentation-of-polyarteritis-nodosa/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-988.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/osteoporotic-vertebral-fractures-as-a-complication-of-long-term-corticosteroid-therapy-in-a-patient-with-systemic-lupus-erythematosus-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-989.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/cardiovascular-system-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-990.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/systemic-lupus-erythematosus-complicated-with-macrophage-activating-syndrome-report-of-a-patient/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-991.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/approach-to-the-patient-with-rheumatoid-arthritis-and-cardiovascular-manifestations-on-biological-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-992.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/the-connection-between-the-use-of-nonsteroidal-antirheumatic-drugs-and-increased-blood-pressure/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-993.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-994.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/the-role-of-the-nurse-in-the-prevention-of-cardiovascular-diseases-in-rheumatology-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-995.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/specifics-of-the-care-for-patients-with-vasculitis-and-cardiovascular-manifestations/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-996.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/specifics-of-healthcare-for-patients-with-rheumatoid-arthritis-ra-and-spondyloarthritis-spa-with-associated-cardiovascular-comorbidities/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-997.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/nurses-competenc-ies-in-cardiovascular-risk-assessment-and-prevention-among-rheumatology-patients-european-and-croatian-perspectives/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-998.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/kawasaki-disease-and-macrophage-activation-syndrome-in-infancy-multidisciplinary-treatment-with-a-focus-on-nursing-care/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-999.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/coexistence-of-rheumatology-and-cardiology-in-thalassotherapia-opatija/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-1000.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/borrelia-burgdoferi-and-pericardial-effusion-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-1001.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/acute-myocardial-infarction-associated-with-psoriatic-arthritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-1002.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2025/Supplement%201/the-role-of-gd-iga1-hmgb1-rage-and-pcdh-1-in-the-pat-hogenesis-of-iga-vasculitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2025/supplement-1/reumatizam-72-27.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/1-2/do-pel-oids-ha-ve-a-role-in-the-treatment-of-chronic-non-speci-fic-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/1-2/reumatizam-71-1.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/media/journals/reumatizam/xml/2024/1-2/reumatizam-71-1.xml 2026-07-17 yearly 0.4 https://www.reumatizam.abol.hr/articles/2024/1-2/adult-onset-stills-disease-in-an-elderly-patient-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/1-2/reumatizam-71-12.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/media/journals/reumatizam/xml/2024/1-2/reumatizam-71-12.xml 2026-07-17 yearly 0.4 https://www.reumatizam.abol.hr/articles/2024/1-2/lymphocytic-interstitial-pneumonitis-and-cryoglobulinemia-as-clues-towards-the-diagnosis-of-sjogrens-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/1-2/reumatizam-71-20.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/media/journals/reumatizam/xml/2024/1-2/reumatizam-71-20.xml 2026-07-17 yearly 0.4 https://www.reumatizam.abol.hr/articles/2024/1-2/world-lupus-day-2024/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/1-2/reumatizam-71-30.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/media/journals/reumatizam/xml/2024/1-2/reumatizam-71-30.xml 2026-07-17 yearly 0.4 https://www.reumatizam.abol.hr/articles/2024/1-2/croatias-participation-at-the-1st-global-angioedema-forum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/1-2/reumatizam-71-35.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/media/journals/reumatizam/xml/2024/1-2/reumatizam-71-35.xml 2026-07-17 yearly 0.4 https://www.reumatizam.abol.hr/articles/2024/1-2/report-from-the-26th-annual-congress-of-the-croatian-society-for-rheumatology-with-international-participation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/1-2/reumatizam-71-39.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/media/journals/reumatizam/xml/2024/1-2/reumatizam-71-39.xml 2026-07-17 yearly 0.4 https://www.reumatizam.abol.hr/articles/2024/1-2/prof-irena-pucar-md-phd-1932-2024/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/1-2/reumatizam-71-48.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/media/journals/reumatizam/xml/2024/1-2/reumatizam-71-48.xml 2026-07-17 yearly 0.4 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/cutaneous-lupus-erythematosus-what-is-new-in-2024/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-874.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/pathophysiology-of-idiopathic-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-875.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/idiopathic-inflammatory-myopathies-clinical-manifestations/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-876.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/pro-muscle-biop-sy-in-diagnostics-of-idiop-athic-inflammator-y-myop-athies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-877.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/against-muscle-biopsy-in-the-diagn-osti-cs-of-idiopat-hic-inflammat-ory-myopat-hies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-878.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/muscle-biopsy-in-diagnostics-of-autoimmune-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1406.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/the-role-of-clinical-electromyoneurography-in-the-diagnosis-of-myositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1407.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/interstitial-lung-disease-in-idiopathic-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1408.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/pharacotherapy-of-idiopathic-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1409.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/rehabilitation-in-myositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1410.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/antibody-profile-in-patients-with-idiopathic-inflammatory-myopathies-and-their-correlation-with-malignancies-a-tertiary-centre-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1411.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/cardiac-manifestations-in-idiopathic-inflammatory-myopathies-experiences-of-a-tertiary-centre/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1412.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/clinical-features-of-patients-with-antisynthetase-syndrome-experience-of-the-single-centre/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1413.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/do-we-still-need-glucocorticoids-in-rheumatoid-arthritis-and-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1414.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/challenges-and-outcomes-of-treatment-of-severe-cases-of-dermatopolymyositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1415.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/evaluation-of-a-screening-algorithm-for-interstitial-lung-diseases-associated-with-systemic-autoimmune-rheumatic-diseases-a-single-center-cross-sectional-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1416.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/d-dimer-as-a-marker-of-inflammation-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1417.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/hla-typing-in-axial-spondyloarthritis-independent-of-hla-b27-positivity/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1418.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/anifrolumab-in-the-treatment-of-systemic-lupus-erythematosus-sle-referral-centre-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1419.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/combination-of-rituximab-and-tofacitinib-in-the-treatment-of-anti-mda-5-antibody-positive-dermatomyositis-case-reports/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1420.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/persistence-and-reasons-for-discontinuation-of-therapy-with-il-17-or-tnf-alpha-inhibitors-in-patients-with-psoriatic-arthritis-experience-of-a-tertiary-center/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1421.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/association-of-cq1-with-the-activity-of-systemic-lupus-erythematosus-with-an-emphasis-on-kidney-affection-a-pilot-project/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1422.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/tocilizumab-induced-hypofibrinogenemia-in-children-witj-juvenile-idiopathic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1423.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/methotrexate-intolerance-severity-score-upitnika-na-hrvatski-jezik/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1425.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/characteristics-and-outcomes-of-patients-with-idiopathic-inflammatory-myopathies-a-single-centre-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1426.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/study-of-reproductive-health-awareness-among-woman-of-reproductive-age-with-systemic-autoimmune-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1427.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/the-significance-of-hyperbaric-oxygen-therapy-in-treating-patients-with-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1428.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/efficacy-of-high-frequency-tecar-therapy-in-patients-with-axial-spondyloarthritis-ankylosing-spondylitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1429.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/diagnostic-and-clinical-significance-of-anti-tif1-antibody-in-patients-with-dermatomyositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1430.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/innovative-approaches-to-patient-care-upon-collaborative-research/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1431.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/the-association-of-global-hemostasis-markers-with-the-risk-of-new-digital-ulcer-onset-circulating-extracellular-vesicles-as-a-predictive-marker-of-interstitial-lung-disease-progression-in-systemic-scl/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1432.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/clinical-and-laboratory-characteristics-of-patients-with-idiopathic-inflammatory-myopathies-and-interstitial-lung-disease-a-single-centre-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1433.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/inflammatory-myopathies-experience-from-our-center-over-a-three-year-period/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1434.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/clinical-manifestations-of-idiopathic-inflammatory-myopathies-experiences-of-a-tertiary-centre/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1435.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/oropharyngeal-dysphagia-in-statin-induced-myositis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1436.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/clinical-manifestations-and-treatment-of-patients-with-behcets-syndrome-a-single-centre-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1437.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/hyperspectral-imaging-tivita-in-the-differentiation-of-microcirculation-of-raynaud-phenomenon/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1438.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/effect-of-treatment-on-creatine-kinase-expression-in-patients-with-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1439.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/adalimumab-in-the-treatment-of-refractory-adult-onset-stills-disease-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1440.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/macroenzyme-explanation-of-an-asymptomatic-increase-in-ck-level/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1441.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/sulfasalazine-induced-nephrotic-syndrome-in-a-patient-with-ankylosing-spondilitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1442.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/infectious-complications-in-a-patient-with-antisynthetase-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1443.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/a-patient-with-a-severe-form-of-polymyositis-and-development-of-acute-tetraparesis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1444.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/isokinetic-exercise-induced-rhabdomyolysis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1445.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/ochronosis-arthropathy-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1446.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/myositis-caused-by-cancer-immunotherapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1447.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/rituximab-as-the-first-line-of-treatment-in-early-dermatomyositis-report-of-a-patient/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1448.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/report-of-a-patient-with-rheumatoid-arthritis-and-atopic-dermatitis-treated-with-baricitinib/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1449.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/overlap-syndrome-systemic-sclerosis-and-polymyositis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1450.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/unplanned-pregnancy-in-patient-with-ankylosing-spondylitis-treated-with-secukinumab/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1451.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/bone-density-disorders-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1452.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/feltys-syndrome-systemic-lupus-erythematosus-or-cytomegalovirus-infection-report-of-a-patient/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1453.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/tardive-dyskinesia-of-the-tongue-and-macroglossia-in-a-patient-with-polymyositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1454.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/complete-resolution-of-the-mitral-valve-vegetation-after-anticoagulant-antiplatelet-and-immunosuppressive-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1455.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/a-follow-up-of-clinical-and-radiographic-signs-in-a-female-patient-with-secondary-sjogrens-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1456.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/c-difficile-a-rare-but-not-less-important-cause-of-reactive-arthritis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1457.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/ischemia-of-the-digits-as-the-primary-manifestation-of-the-antisynthetase-syndrome-in-a-patient-with-pl12-and-ro52-antibodies-report-of-a-patient/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1458.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/large-vessel-vasculitis-in-a-patient-with-spondyloarthritis-treated-with-certolizumab-pegol-report-of-a-patient/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1459.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/recurrent-myopericarditis-as-a-presenting-manifestation-of-anti-synthetase-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1460.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/rapidly-progressive-interstitial-lung-disease-in-a-patient-with-amyopathic-anti-mda-5-positive-dermatomyositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1461.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/patient-with-mda5-positive-amyopathic-dermatomyositis-treated-with-mycophenolate-mofetil-and-tacrolimus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1462.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/arthritis-associated-with-mycoplasma-pneumoniae-infection/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1463.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/pembrolizumab-induced-myositis-arthritis-and-peripheral-neuropathy-in-a-patient-with-metastatic-lung-cancer-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1464.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/a-case-report-of-myositis-mimicker-caused-by-hypocalcemia-and-hypomagnesiemia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1465.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/idiopathic-inflammatory-myopathies-role-of-the-nurse/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1466.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/polymyositis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1467.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/toxic-myopathy-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1468.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/patient-with-the-diagnosis-of-polymyositis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1469.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/anti-synthetase-syndrome-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1470.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/effects-of-nutritional-status-on-the-quality-of-life-of-patients-with-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1471.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/specific-features-in-the-care-of-patients-with-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1472.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/optimism-and-life-goals/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1473.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/the-role-of-the-nurse-in-the-care-of-patients-with-myositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1474.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/the-role-of-physiotherapists-and-occupational-therapists-in-an-interdisciplinary-approach-to-rheumatological-and-immunological-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1475.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/importance-of-the-insight-into-health-literacy-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1476.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/over-60-patients-inadequately-store-biological-drugs-challenges-and-solutions-in-temperature-monitoring/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1477.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2024/Supplement%201/challenges-of-nurses-in-caring-for-patients-suffering-from-juvenile-dermatomyositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2024/supplement-1/reumatizam-71-1478.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/2/osvrt-na-kraju-mandata-glavnog-urednika-casopisa-reumatizam-2014-2023/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/2/reumatizam-70-57.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/2/lung-diseases-in-rheumatoid-arthritis-experiences-of-a-tertiary-centre/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/2/reumatizam-70-63.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/2/massive-stroke-in-a-young-male-patient-as-a-manifestation-of-takayasus-arteritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/2/reumatizam-70-71.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/2/first-description-of-a-female-patient-with-advanced-ankylosing-spondylitis-and-polymyalgia-rheumatica-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/2/reumatizam-70-76.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/2/reversible-oligospermia-in-a-patient-with-non-radiographic-axial-spondyloarthritis-due-to-sulfasalazine-treatment-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/2/reumatizam-70-85.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/2/antiphospholipid-syndrome-and-pregnancy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/2/reumatizam-70-91.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/immunobiology-of-intestinal-mucosa-from-local-immunity-and-microbiome-to-inflammation-of-joints/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-785.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/main-challenges-in-systemic-lupus-erythematosus-in-2023/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-793.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/immune-related-adverse-events-of-immune-checkpoint-inhibitors-the-debrecen-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-794.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/the-impact-of-co-vid-19-pandemic-on-fatigue-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-807.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/the-clinical-characteristics-of-psoriatic-arthritis-a-cross-sectional-st-udy-based-on-the-psoriatic-arthritis-cohort-of-sp-ecial-hospital-for-medical-rehabilitation-naftalan-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-811.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/the-vienna-sle-database-first-results/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-817.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/case-report-of-rhupus-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-839.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/speckle-tracking-echocardiography-in-diagnosis-and-follow-up-of-egpa-myocarditis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-846.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/how-we-started-with-the-fracture-liaison-service-in-clinical-center-of-vojvodina/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-848.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/Supplement%201/authors-index/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/supplement-1/reumatizam-70-1404.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/1/impressum/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/1/reumatizam-70-779.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/1/content/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/1/reumatizam-70-1405.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/1/the-effect-of-an-innovative-cream-on-pain-mobility-functional-ability-and-quality-of-life-in-patients-with-non-specific-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/1/reumatizam-70-1.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/1/novel-nlrp12-variant-in-a-patient-with-cold-induced-autoinflammatory-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/1/reumatizam-70-10.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/1/papa-syndrome-diagnostic-and-therapeutic-pa-th-from-pa-ediatric-to-adult-rheumatologist/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/1/reumatizam-70-15.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/1/chronic-recurrent-multifocal-osteomyelitis-crmo-of-pelvis-and-spine-in-a-paediatric-patient-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/1/reumatizam-70-24.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2023/1/immunomodulatory-antirheumatic-drugs-and-non-steroidal-anti-inflammatory-drugs-in-pre-conception-pregnancy-and-breastfeeding-a-review-of-the-guidelines/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2023/1/reumatizam-70-34.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/content/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-776.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/impressum/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-777.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/impressum-1177/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-778.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/cijepljenje-djece-s-reumatskim-bolestima-protiv-covid-19-i-influence/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-77.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/klinicka-slika-i-lijecenje-stillove-bolesti-u-odraslih-iskustva-jednog-centra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-90.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/dugotrajno-pracenje-kompleksnog-pacijenta-s-obicnom-varijabilnom-imunodeficijencijom-prikaz-bolesnika/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-103.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/rana-primjena-ciklofosfamida-u-lijecenju-novonastale-progresivne-kozne-sistemske-skleroze-prikaz-bolesnika-i-pregled-literature/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-110.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/toksicna-epidermalna-nekroliza-inducirana-ibuprofenom-prikaz-bolesnika/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-117.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/izazovi-u-tretmanu-neuro-behcetove-bolesti-prikaz-bolesnika/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-124.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/2/prof-dr-sc-theodor-durrigl-10-10-1926-20-7-2022/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/2/reumatizam-69-132.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/1/impressum-202201/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/1/reumatizam-69-768.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/1/spolne-razlike-u-sjogrenovu-sindromu-desetogodisnje-iskustvo-jednog-centra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/1/reumatizam-69-01.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/1/povezanost-koznih-manifestacija-i-klinickih-znacajki-iga-vaskulitisa/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/1/reumatizam-69-14.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/1/ucestalost-tromboembolijskih-dogaaja-u-sistemskom-obliku-vaskulitisa-i-lokaliziranom-koznom-vaskulitisu/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/1/reumatizam-69-24.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/1/ishod-i-tijek-bolesti-covid-19-kod-bolesnika-s-upalnim-reumatskim-bolestima-koji-su-na-bioloskoj-ili-ciljanoj-sintetskoj-modificirajucoj-terapiji-rezultati-jednoga-reumatoloskog-centra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/1/reumatizam-69-32.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/1/dijagnoza-i-klasifikacijski-kriteriji-sjogrenovog-sindroma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/1/reumatizam-69-41.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/1/povezanost-bioloske-terapije-i-malignih-bolesti-u-upalnim-reumatskim-bolestima/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/1/reumatizam-69-55.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/Supplement%201/evidence-based-non-pharmacological-treatment-of-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/supplement-1/reumatizam-69-746.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/Supplement%201/the-main-topic-of-the-congress/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/supplement-1/reumatizam-69-747.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/Supplement%201/invited-lectures/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/supplement-1/reumatizam-69-748.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/Supplement%201/oral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/supplement-1/reumatizam-69-749.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/Supplement%201/young-rheumatology/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/supplement-1/reumatizam-69-750.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/Supplement%201/posters/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/supplement-1/reumatizam-69-751.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/Supplement%201/allied-health-professionals/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/supplement-1/reumatizam-69-752.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2022/Supplement%201/patients-societies/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2022/supplement-1/reumatizam-69-753.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/2/impressum/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/2/reumatizam-68-754.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/2/systemic-manifestations-of-sjogrens-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/2/reumatizam-68-755.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/2/anticoagulation-an-overview-of-pharmacological-agents-and-therapeutic-implications-in-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/2/reumatizam-68-756.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/2/indolent-extranodal-b-nhl-cd20-positive-malt-lymphoma-in-a-patient-with-primary-sjogrens-syndrome-with-a-good-response-to-rituximab-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/2/reumatizam-68-757.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/2/tuberculosis-spondylodiscitis-in-a-patient-with-psoriatic-arthritis-on-targeted-synthetic-disease-modifying-antirheumatic-drugs-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/2/reumatizam-68-758.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/2/therapeutic-approach-to-a-patient-with-antisynthetase-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/2/reumatizam-68-759.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/2/80th-anniversary-of-the-department-of-rheumatology-physical-and-rehabilitation-medicine-of-the-sestre-milosrdnice-uhc-in-zagreb/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/2/reumatizam-68-760.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/1/povezanost-klinickih-i-patohistoloskih-nalaza-u-bolesnika-sa-suspektnim-primarnim-sjogrenovim-sindromom/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/1/reumatizam-68-736.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/1/klinicka-obiljezja-reumatske-polimialgije-iskustva-jednog-centra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/1/reumatizam-68-737.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/1/klinicke-i-laboratorijske-znacajke-iga-vaskulitisa-s-gastrointestinalnom-zahvacenoscu-dvanaestogodisnje-iskustvo-referentnog-centra-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/1/reumatizam-68-738.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/1/vaskulitisi-crijeva-kao-ocitovanja-raznih-sustavnih-autoimunih-bolesti-lijeceni-u-klinickom-bolnickom-centru-split-u-desetogodisnjem-razdoblju/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/1/reumatizam-68-739.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/1/sistemska-skleroza-kod-starijeg-bolesnika-prikaz-bolesnika-i-pregled-literature/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/1/reumatizam-68-740.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/1/misicno-kostani-poremecaji-i-bolesti-kod-pijanista-pouke-iz-proslosti-i-poruke-mladima/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/1/reumatizam-68-741.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/patients-societies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-727.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/allied-health-professionals/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-728.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/posters/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-729.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/free-topics-oral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-730.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/young-rheumatology-oral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-731.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/sjogrens-syndrome-oral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-732.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/sjogrens-syndrome-invited-lectures/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-733.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/invited-lectures-oral-communications/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-734.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/classification-criteria-for-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-735.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/invited-lectures-oral-communications-online-rheumatology-research-and-publishing-amidst-the-covid-19-pandemi/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-1401.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/authors-index/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-1402.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2021/Supplement%201/invited-lectures-oral-communications-additional-heterologous-versus-homologous-booster-vaccination-in-immunosuppressed-patients-without-sars-cov-2-antibody-seroconversion-after-primary-mrna-vaccinatio/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2021/supplement-1/reumatizam-68-1403.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/2/professor-sylejman-rexhepi-md-phd-6-november-1953-24-july-2020/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/2/reumatizam-67-721.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/2/sacral-insufficiency-fractures-a-commonl-y-overlooked-cause-of-low-back-and-pelvic-pain-a-case-report-and-literature-review/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/2/reumatizam-67-722.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/2/evidence-based-non-pharmacological-treatment-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/2/reumatizam-67-723.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/2/kidney-involvement-in-adults-with-iga-vasculitis-experiences-from-clinical-hospital-dubrava-zagreb/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/2/reumatizam-67-724.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/2/new-parameters-of-hand-grip-in-rheumatoid-arthritis-patients-based-on-electrodynamic-measurements-a-pilot-evaluation-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/2/reumatizam-67-725.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/2/treatment-of-giant-cell-arteritis-using-tocilizumab/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/2/reumatizam-67-726.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/1/pubic-symphysis-diastasis-in-twin-pregnancy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/1/reumatizam-67-709.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/1/when-to-suspect-an-autoinflammatory-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/1/reumatizam-67-710.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/1/effect-of-disease-activity-and-functional-impairment-in-patients-with-rheumatoid-arthritis-on-satisfaction-with-provided-rheumatology-health-care/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/1/reumatizam-67-711.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/1/non-pharmacological-treatment-of-painful-shoulder-syndrome-comparative-research/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/1/reumatizam-67-712.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/1/gender-differences-in-clinical-manifestations-and-comorbidities-in-patients-with-sle-a-single-center-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/1/reumatizam-67-713.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/patients-societiesoral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-714.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/allied-health-professionalsoral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-715.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/progressive-systemic-sclerosis-in-the-elderly-a-literature-review-and-case-report/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-716.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/young-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-717.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/oral-comunications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-718.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/invited-lecturesoral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-719.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/gerontorheumatologyinvited-lectures/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-720.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/gerontorheumatology-invited-lectures-sarcopenia-and-osteoporotic-fractures-in-elderly-patients-with-arthritis-news-in-the-treatment-of-osteoarthritis-elderly-onset-rheumatoid-arthritis-what-do-we-know/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-1399.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2020/Supplement%201/posters/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2020/supplement-1/reumatizam-67-1400.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/Supplement%201/the-role-of-ultrasound-in-rheumatology-past-present-and-future/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/supplement-1/reumatizam-66-1393.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/Supplement%201/invited-speakersoral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/supplement-1/reumatizam-66-1394.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/Supplement%201/oral-communications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/supplement-1/reumatizam-66-1395.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/Supplement%201/posters/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/supplement-1/reumatizam-66-1396.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/Supplement%201/allied-health-professionals/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/supplement-1/reumatizam-66-1397.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/Supplement%201/patients-societies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/supplement-1/reumatizam-66-1398.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/2/atypical-presentation-of-antisynthetase-syndrome-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/2/reumatizam-66-704.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/2/ultrasound-evaluation-of-the-ankle-joints-and-tendons-in-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/2/reumatizam-66-705.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/2/giant-cell-arteritis-in-a-patient-with-bilateral-parotid-swelling-as-the-first-sign-of-the-disease-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/2/reumatizam-66-706.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/2/pandas-diagnostic-and-therapeutic-challenges-case-report-and-literature-review/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/2/reumatizam-66-707.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/2/comparison-of-radiographic-and-ultrasonographic-features-of-painful-shoulder-in-rheumatoid-arthritis-in-relation-to-painful-shoulder-of-non-inflammatory-cause/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/2/reumatizam-66-708.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/1/effectiveness-of-biologics-in-patients-with-rheumatoid-arthritis-a-single-center-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/1/reumatizam-66-697.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/1/biologic-therapy-and-pregnancy-a-tertiary-center-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/1/reumatizam-66-698.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/1/case-report-of-a-patient-with-canca-vasculitis-without-airway-involvement/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/1/reumatizam-66-699.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/1/osteitis-pubis-and-osteomyelitis-pubis-in-pregnancy-two-case-reports/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/1/reumatizam-66-700.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/1/the-importance-of-antenatal-ultrasound-screening-for-congenital-osteochondrodysplasia-two-case-reports/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/1/reumatizam-66-701.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2019/1/12th-central-european-congress-of-rheumatology-and-20th-annual-congress-of-the-croatian-society-for-rheumatology/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2019/1/reumatizam-66-702.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/influence-of-mediterranean-diet-on-incidence-and-course-of-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1365.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/causes-of-early-and-late-death-and-survival-of-sle-patients-over-a-10-year-period-analysis-from-a-croatian-tertiary-center/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1366.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/disease-activity-and-damage-index-in-110-sle-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1367.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/ultrasound-evaluation-of-the-ankle-joints-and-tendons-in-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1368.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/giant-cell-arteritis-an-overview/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1369.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/early-diagnosis-of-giant-cell-arteritis-does-it-matter/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1370.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/colour-doppler-sonography-of-facial-and-occipital-arteries-in-patients-with-giant-cell-arteritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1371.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/mri-in-evaluation-of-inflammatory-myopathy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1372.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/survival-and-subset-classification-analysis-of-82-patients-with-inflammatory-myopathy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1373.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/risk-factors-for-extra-articular-signs-in-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1374.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/sapho-syndrome-clinical-symptoms-imaging-and-treatment-based-on-a-group-of-polish-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1375.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/highlights-and-pitfalls-of-mri-imaging-in-axial-spondyloarthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1376.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/importance-of-trabecular-bone-score-in-fracture-risk-prediction-in-rheumatoid-arthritis-and-ankylosing-spondylitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1377.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/temporomandibular-joint-arthritis-and-the-role-of-imaging/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1378.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/biomarkers-in-rheumatology-what-do-we-really-know/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1379.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/biomarkers-in-axial-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1380.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/mirnas-as-biomarkers-in-autoimmune-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1381.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/the-differences-between-clinical-manifestations-and-comorbidities-between-women-and-men-with-sle-treated-in-university-hospital-of-split-from-january-2007-to-december-2017/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1382.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/childhood-onset-systemic-lupus-erythematosus-over-the-last-25-years-predicting-organ-damage/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1383.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/cognitive-dysfunction-in-systemic-lupus-erythematosus-is-more-associated-with-non-inflammatory-mechanism-than-inflammation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1384.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/disease-activity-and-treatment-patterns-in-patients-with-rheumatoid-arthritis-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1385.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/difficult-to-treat-a-patient-with-rheumatoid-arthritis-and-t-cell-large-granular-lymphocyte-leukemia-t-lgll/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1386.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/giant-cell-arteritis-in-poland-how-to-increase-diagnostic-rate/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1387.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/the-occurrence-of-paraneoplastic-syndromes-in-patients-with-polymyalgia-rheumatica-treated-at-the-university-hospital-center-osijek/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1388.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/diagnosis-and-management-of-patients-with-granulomatosis-with-polyangiitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1389.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/clinical-course-of-systemic-sclerosis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1390.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/oral-communications-young-rheumatologists-oralna-priopcenja-mlada-reumatologija/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1391.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/Supplement%201/posters-posteri/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/supplement-1/reumatizam-65-1392.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/2/surgical-treatment-of-the-rheumatoid-foot/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/2/reumatizam-65-689.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/2/total-joint-arthroplasty-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/2/reumatizam-65-690.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/2/spinal-surgery-in-inflammatory-rheumatic-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/2/reumatizam-65-691.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/2/hand-surgery-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/2/reumatizam-65-692.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/2/recommendations-for-biological-therapy-treatment-in-patients-undergoing-surgical-procedures-of-the-musculoskeletal-system/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/2/reumatizam-65-693.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/2/abstracts/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/2/reumatizam-65-694.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/1/enteropathic-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/1/reumatizam-65-681.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/1/nutritional-status-in-patients-with-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/1/reumatizam-65-682.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/1/a-comparison-of-the-effectiveness-of-tocilizumab-and-tnf-inhibitors-in-the-treatment-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/1/reumatizam-65-683.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/1/clinical-features-of-malignancies-in-patients-with-systemic-lupus-erythematosus-a-10-year-data-from-university-hospital-split/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/1/reumatizam-65-684.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/1/identification-of-a-corpse-suffering-from-gout-a-historical-case-of-chiragra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/1/reumatizam-65-685.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2018/1/correlation-of-routine-assessment-of-patient-index-data3-score-rapid3-with-disease-activity-score-28-das28-and-health-assessment-questionnaire-haq-in-patients-with-rheumatoid-and-psoriatic-arthritis-o/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2018/1/reumatizam-65-688.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/systemic-sclerosis-an-overview/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1353.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/epidemiology-of-and-classification-criteria-for-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1354.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/pathogenesis-of-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1355.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/clinical-manifestations-of-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1356.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/enthesitis-and-dactylitis-manifestations-of-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1357.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/psoriasis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1358.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/comorbidities-in-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1359.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/psoriatic-arthritis-imaging-an-overview-and-update/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1360.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/measuring-disease-activity-in-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1361.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/pharmacological-treatment-of-patients-with-psoriatic-arthritis-symptomatic-drugs-and-conventional-synthetic-disease-modifying-antirheumatic-drugs/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1362.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/treatment-of-psoriatic-arthritis-with-biological-and-targeted-synthetic-drugs/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1363.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/Supplement%201/non-pharmacological-treatment-of-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/supplement-1/reumatizam-64-1364.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/2/2017-recommendation-proposal-of-the-croatian-society-of-rheumatology-for-the-treatment-of-patients-with-rheumatoid-arthritis-with-biologic-drugs-and-targeted-synthetic-drugs/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/2/reumatizam-64-669.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/2/2017-recommendation-proposal-of-the-croatian-society-of-rheumatology-for-the-treatment-of-adults-with-axial-spondyloarthritis-and-psoriatic-arthritis-with-biologic-drugs-and-targated-synthetic-drugs/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/2/reumatizam-64-670.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/2/effects-of-diet-lifestyle-and-other-environmental-factors-on-the-incidence-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/2/reumatizam-64-671.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/2/discontinuation-of-biologics-in-patients-with-juvenile-idiopathic-arthritis-after-achieving-clinical-remission-experience-of-the-republic-of-croatia-referral-center-for-pediatric-and-adolescent-rheuma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/2/reumatizam-64-672.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/2/short-term-efficacy-of-ultrasound-and-laser-therapy-in-carpal-tunnel-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/2/reumatizam-64-673.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/2/intermetatarsal-bursitis-as-a-manifestation-of-rheumatoid-arthritis-a-case-presentation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/2/reumatizam-64-674.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/2/lymphedema-distichiasis-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/2/reumatizam-64-675.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/1/systemic-lupus-erythematosus-description-and-quantification-of-the-disease-phenotype/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/1/reumatizam-64-1.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/1/new-concepts-in-the-pathophysiology-and-treatment-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/1/reumatizam-64-10.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/1/cervical-spine-fracture-in-a-patient-with-ankylosing-spondylitis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/1/reumatizam-64-22.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/1/pure-red-blood-cell-aplasia-in-systemic-lupus-erythematosus-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/1/reumatizam-64-26.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2017/1/congenital-osteochondrodysplasia-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2017/1/reumatizam-64-30.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/classification-and-diagnosis-of-axial-spondyloarthritides-history-present-state-and-perspectives/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1338.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/etiology-and-pathogenesis-of-pain-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1339.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/clinical-entities-and-characteristics-of-pain-in-patients-with-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1340.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/fibromyalgia-is-it-a-rheumatic-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1341.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/evaluation-of-pain-and-local-pharmacological-pain-treatment-in-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1342.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/systemic-pharmacological-treatment-of-pain-in-rheumatic-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1343.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/non-pharmacological-pain-management-of-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1344.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/juvenile-idiopathic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1345.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/juvenile-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1346.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/autoimmunity-and-immunodeficiencies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1347.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/radiological-features-in-pediatric-imaging/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1348.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/vasculitides-in-childhood/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1349.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/rheumatology-in-pediatric-cardiology-from-fetal-stage-to-adulthood-the-role-of-fetal-echocardiography/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1350.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/the-importance-of-transition-in-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1351.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/Supplement%201/diagnostic-ultrasound-of-musculoskeletal-system-in-rheumatology-in-croatia-current-status-and-new-perspectives/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/supplement-1/reumatizam-63-1352.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/2/effect-of-disease-modifying-antirheumatic-drugs-on-the-values-of-apolipoprotein-a-1-and-acute-phase-reactants-in-patients-with-active-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/2/reumatizam-63-7.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/2/3rd-national-kosovo-rheumatology-congress-with-international-participation-2016-prishtina-november-34-2016/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/2/reumatizam-63-15_7Swf1nU.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/1/pregnant-patient-with-rheumatoid-arthritis-treated-with-methotrexate-and-infliximab-170/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/1/reumatizam-63-23.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/1/pregnant-patient-with-rheumatoid-arthritis-treated-with-methotrexate-and-infliximab-171/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/1/reumatizam-63-24.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/2/myocardial-infarction-as-a-consequence-of-childhood-polyarteritis-nodosa-case-repor/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/2/reumatizam-63-1337.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/2/vagal-nerve-stimulation-in-the-treatment-of-patients-with-rheumatoid-arthritis-results-through-day-84-obtained-at-the-croatian-center-of-an-international-pilot-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/2/reumatizam-63-1.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/1/late-onset-rheumatoid-arthritis-an-observational-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/1/reumatizam-63-1.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/1/pregnant-patient-with-rheumatoid-arthritis-treated-with-methotrexate-and-infliximab/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/1/reumatizam-63-6.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/1/polymyositis-and-systemic-sclerosis-overlap-a-case-report-and-a-review-of-the-literature/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/1/reumatizam-63-10.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/1/long-term-glucocorticoid-therapy-and-the-rapid-development-of-squamous-cell-carcinoma-in-systemic-sclerosis-is-there-a-connection/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/1/reumatizam-63-14.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/2/myocardial-infarction-as-a-consequence-of-childhood-polyarteritis-nodosa-case-report/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/2/reumatizam-63-15.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/1/controlled-release-oxycodone-in-the-treatment-of-chronic-musculoskeletal-pain-a-preliminary-experience-of-a-rheumatology-center/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/1/reumatizam-63-20.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2016/2/pericardial-features-of-in-hospital-rheumatology-patients-an-observational-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2016/2/reumatizam-63-21.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/overall-characteristics-and-early-diagnosis-of-patients-with-connective-tissue-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1321.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/the-challenge-of-early-knee-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1322.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/osteoarthritis-a-mechanical-disorder-or-an-inflammatory-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1323.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/the-role-of-biomarkers-in-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1324.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/early-vs-advanced-osteoarthritis-from-a-radiological-aspect/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1325.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/recommendations-and-guidelines-for-the-treatment-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1326.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/ostheoarthritis-exercise-as-a-disease-modifying-drug-dmard/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1327.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/surgical-treatment-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1328.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/early-scleroderma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1329.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/rheumatic-diseases-and-malignansy-where-is-the-association/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1330.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/paraneoplastic-syndromes-in-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1331.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/sjogrens-syndrome-and-lymphoproliferative-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1332.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/treatment-of-rheumatic-diseases-and-malignancy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1333.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/polymyalgia-rheumatica-giant-cell-arteritis-and-malignancy-is-there-an-association/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1334.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/systemic-sclerosis-and-malignant-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1335.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/Supplement%201/diagnostic-ultrasound-of-the-musculoskeletal-system-the-importance-of-standardization-of-ultrasound-findings/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/supplement-1/reumatizam-62-1336.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/1/impact-of-morning-stiffness-education-and-age-on-the-functional-status-of-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/1/reumatizam-62-6.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/2/vasculitides-in-childhood-a-retrospective-study-in-a-period-from-2002-to-2012-at-the-department-of-paediatrics-university-hospital-centre-zagreb/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/2/reumatizam-62-6.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/2/rheumatology-in-europe-in-2015/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/2/reumatizam-62-11.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/1/retrospective-data-analysis-of-the-patients-with-inflammatory-joint-diseases-treated-with-golimumab-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/1/reumatizam-62-12.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/2/bone-mineral-density-in-patients-with-systemic-lupus-erythematosus-our-results/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/2/reumatizam-62-16.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/1/pathogenesis-of-undifferentiated-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/1/reumatizam-62-20.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/2/takayasu-arteritis-and-possible-cardiology-repercussions-in-the-childhood/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/2/reumatizam-62-22.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2015/1/cryoglobulinemic-vasculitis-as-a-manifestation-of-paraneoplastic-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2015/1/reumatizam-62-27.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/characteristics-of-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-86.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/relapsing-polychondritis-an-early-manifestation-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-87.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/meningitis-as-the-first-manifestation-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-88.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/efficacy-and-safety-of-tocilizumab-treatment-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-89_ekgFL4j.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-side-effects-of-biologic-therapy-in-children-with-rheumatic-diseases-a-5-year-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-90.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/qualitative-analysis-of-dermatoglyphics-of-digitopalmar-complex-in-twenty-classical-psoriatic-arthritis-female-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-91.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/qualitative-analysis-of-dermatoglyphics-of-digitopalmar-complex-in-twenty-male-symmetrical-psoriatic-polyarthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-92.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/qualitative-analysis-of-dermatoglyphics-of-digitopalmar-complex-in-twenty-psoriatic-spondylitis-female-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-93.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/qualitative-analysis-of-dermatoglyphics-of-digitopalmar-complex-in-twenty-psoriatic-oligoarthritis-male-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-94.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-role-of-ampk-in-pathogenesis-of-fibromyalgia-new-therapeutic-possibilities/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-95_Ojo7Mqo.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-importance-of-comorbidity-in-treatment-of-gouty-arthritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-96.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/complex-rehabilitation-of-female-patient-with-shoulder-stiffness-after-total-mastectomy-treated-with-m-latissimus-dorsi-transfer-chemotherapy-and-irradiation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-97.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/prevalence-and-clinical-features-of-sjogrens-syndrome-in-dalmatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-98.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-patient-with-systemic-sclerosis-and-squamous-cell-lung-carcinoma-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-99.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/percutaneous-intradiscal-application-of-discogel-in-disc-herniation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-100_ub1b1lm.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/liver-and-kidney-sarcoidosis-with-brain-demyelination-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-101.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/osteoporosis-in-patients-with-parkinsons-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-102.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/osteoporosis-and-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-103.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/secondary-prevention-in-patients-with-low-energy-hip-fracture-program-of-the-university-clinical-centre-sestre-milosrdnice-zagreb/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-104.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/bone-mineral-density-disorder-in-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-105_2OGu3x4.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/disease-activity-and-bone-mineral-density-in-patients-with-rheumatoid-arthritis-and-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-106.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-connection-between-anxiety-and-depression-with-forms-of-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-107.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/posterior-reversible-encephalopathy-syndrome-in-a-young-sle-patient-treated-with-cyclophosphamide/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-108.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/arthritis-following-intravesical-treatment-of-the-urinary-bladder-carcinoma-with-bacillus-calmette-guerin-bcg/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-109.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/do-we-pay-enough-attention-to-neuropathic-component-in-knee-osteoarthritis-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-110.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/gigantocellular-aortitis-diagnosed-by-pet-ct-a-paraneoplastic-syndrome-in-a-patient-with-lung-cancer/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-111.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/macrophage-activation-syndrome-induced-by-relapse-of-adult-stills-disease-treated-with-glucocorticoids-intravenous-immunoglobulin-cyclosporines-and-anakinra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-112.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/balance-assessment-in-hospitalized-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-113.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/human-immunodefi-ciency-virus-hiv-infection-mimicking-systemic-connective-tissue-diseases-a-case-report/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2014/2/guideline-for-non-steroidal-anti-infl-ammatory-drug-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-115.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/demographic-clinical-and-laboratory-features-of-children-with-juvenile-dermatomyositis-in-croatia-from-1990-to-2013/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-116.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/transitional-rheumatologic-outpatient-care-our-first-experiences/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-117.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/temporomandibular-joint-involvement-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-118.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/oxycodone-in-the-treatment-of-strong-chronic-musculoskeletal-joint-pain-our-experiences/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-119.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/gastrointestinal-manifestations-of-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-120.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/rheumatology-in-europe-in-2015/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-121.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/personalized-approach-to-the-patient-with-rheumatoid-arthritis-new-insights-and-new-possibilities/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-122.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-use-of-biosimilar-infliximab-in-the-treatment-of-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-123.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/reduced-possibility-of-self-care-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-124.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-incidence-of-biologics-monotherapy-in-the-treatment-of-rheumatoid-arthritis-world-wide-experiences/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-125.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/questionnaire-for-patients-taking-methotrexate/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-126.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-127.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/prevention-of-falls-in-hospital-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-128.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/hands-the-most-important-region-affected-by-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-129.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/biological-drugs-in-the-treatment-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-130.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-application-of-parathyroid-hormone-in-the-treatment-of-osteoporosis-caused-by-glucocorticoid-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-131.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/osteoporosis-and-the-role-of-nurse-in-patient-education/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-132.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/osteoporosis-prevention-of-fractures-and-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-133.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/osteoporosis-and-primary-prevention/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-134.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-effectiveness-of-ten-day-physiotherapy-on-hand-strength-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-135.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-positive-effect-of-exercise-in-the-prevention-and-treatment-of-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-136.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-pathophysiology-of-rheumatoid-arthritis-and-mechanism-of-action-of-subcutaneous-tocilizumab/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-137.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/incidence-of-ulcerations-in-systemic-sclerosis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-138.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/health-tourism-and-its-impact-on-nursing/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-139.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/teamwork-in-the-rehabilitation-of-amputees/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-140.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/sports-and-recreational-activities-in-patients-with-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-141.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/sport-and-recreational-activities-in-patients-with-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-142.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/sports-and-recreational-activities-in-patients-with-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-143.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/sports-and-recreational-activities-of-persons-suffering-from-degenerative-joint-and-spinal-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-144.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/presenting-back-to-life-campaign/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-145.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/tai-chi-in-patients-with-musculoskeletal-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-146.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/rheumatic-diseases-and-risk-for-cardiovascular-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-147.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-necessity-of-manual-therapy-and-therapeutic-recreational-activities-in-patients-with-progressive-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-148.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/sports-and-recreational-activities-in-persons-with-collagenoses/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-149.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/natural-remedies-in-the-treatment-of-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-150.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/novel-treatment-possibilities-of-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-151.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-1309.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-1310.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/instructions-for-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-1311.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1312.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1313.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/programme-sixteenth-annual-congress-of-the-croatian-society-for-rheumatology-of-the-cma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1314.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/programme-25th-education-course-for-nurses-and-physiotherapists/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1315.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/programme-meeting-of-patients-associations-representatives/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1316.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/human-immunodeficiency-virus-hiv-infection-mimicking-systemic-connective-tissue-diseases-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1317.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1318.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/instructions-for-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1319.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-patient-with-multicentric-pulmonary-castlemans-disease-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-1320.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/structural-changes-on-hands-as-predicative-factors-of-structural-changes-in-the-cervical-spine-and-atlantoaxial-joint-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-7.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/epidemiology-of-infl-ammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-13.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/analysis-of-the-course-of-rheumatoid-arthritis-depending-on-the-climatic-and-geographic-zones-of-uzbekistan/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-13.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/sex-hormones-immune-disorders-and-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-17.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/pathogenesis-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-19.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/genetic-predisposition-for-various-forms-of-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-23.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/clinical-approach-to-a-patient-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-24.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/comorbidities-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-31.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/the-significance-of-innate-immunity-in-juvenile-idiopathic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-32.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/application-of-radiological-imaging-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-37.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/1/henoch-schonlein-purpura-with-late-onset-necrotising-glomerulonephritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/1/reumatizam-61-40.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-role-of-diagnostic-ultrasound-of-hands-and-feet-in-the-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-43.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-treatment-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-55.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/epidemiology-of-osteoporosis-and-osteoporotic-fractures/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-60.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/pathophysiology-of-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-65.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/bone-densitometry-the-gold-standard-for-diagnosis-of-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-70.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/diagnostics-and-treatment-of-osteoporotic-vertebral-fractures/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-75.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/the-role-of-vitamin-d-and-calcium-in-the-management-of-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-80.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/antiresorptive-agents-in-the-treatment-of-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-89.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/osteoanabolics-and-the-forthcoming-drugs-for-the-treatment-of-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-95.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/non-pharmacological-treatment-of-osteoporosis-myth-or-reality/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-100.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2014/2/glucocorticoid-induced-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2014/2/reumatizam-61-105.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/vasculitis-with-kidney-infarction-as-a-presentation-of-sle-in-a-male-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-170.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/development-of-iga-nephropathy-in-a-patient-with-abdominal-form-of-henoch-schonlein-purpura-successfully-treated-with-mycophenolate-mofetil-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-171.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/glomerulonephritis-in-henoch-schonlein-purpura-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-172.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/mixed-cryoglobulinemia-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-173.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/clinical-manifestations-diagnosis-and-treatment-of-patients-with-temporal-arteritis-in-clinical-hospital-center-rijeka/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-174.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/cryoglobulinemia-in-paraneoplastic-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-175.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/aortitis-in-systemic-lupus-erythematosus-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-176.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/early-diagnosis-and-treatment-of-microscopic-polyangiitis-preserves-the-function-of-the-affected-organ/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-177.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/mononeuritis-multiplex-and-eosinophilic-pleural-effusion-as-first-manifestation-of-churg-strauss-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-178.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/polymyalgia-rheumatica-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-179.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/prognostic-value-of-hla-b27-antigen-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-180.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/rapid-3-practical-and-reliable-tool-for-evaluation-of-the-disease-activity-in-patients-with-inflammatory-rheumatic-joint-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-181.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/cardiovascular-morbidity-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-182.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/viral-arthritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-183.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/radiologic-changes-of-the-cervical-spine-and-the-atlanto-axial-joint-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-184.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/sonographic-examination-of-painful-shoulder-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-185.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/ultrasound-therapy-in-treatment-of-symptomatic-calcific-tendinitis-of-the-shoulder/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-186.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/medial-and-lateral-epicondylitides-of-elbow-in-the-outpatient-physiatrist-through-a-year/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-187.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/low-back-pain-m-piriformis-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-188.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/groin-pain-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-189.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/fibromyalgia-therapeutic-effect-of-coenzyme-q10/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-190.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/effiacy-and-safety-of-tnf-inhibitors-use-in-patients-with-ankylosing-spondylitis-and-total-spinal-ankylosis-in-croatia-a-one-year-follow-up/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-191.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/comparison-of-the-number-of-tender-and-swollen-joints-by-self-assessment-and-physician-assessment-in-patients-with-rheumatoid-arthritis-preliminary-results/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-192.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/pregnancy-in-a-patient-with-rheumatoid-arthritis-treated-with-methotrexate-and-infliximab-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-193.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/why-do-we-terminate-biologic-therapy-a-retrospective-analysis-of-249-patients-during-a-7-year-period/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-194.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/causes-of-death-of-103-patients-with-systemic-lupus-erythematosus-retrospective-analysis-of-patients-death-certificates-in-croatia-from-2002-to-2009/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-195.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/characteristics-of-tuberculosis-in-patients-with-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-196.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/when-to-think-of-isolated-cns-vasculitis-in-patients-with-neurological-disorders-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-197.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/comparative-results-of-stir-and-t1-fs-with-contrast-medium-sequence-in-magnetic-resonance-of-sacroiliac-joints/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-198.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/physical-activity-in-patients-with-diabetes-mellitus-type-1/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-199.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/sapho-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-200.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/gout-and-comorbidities-in-outpatient-practice/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-201.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/association-of-celiac-disease-and-rheumatic-diseases-case-reports/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-202.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/asas-health-index-translation-to-croatian-language-and-preliminary-results-of-developing-an-instrument-specifi-c-for-axial-spondyloarthritis/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/vagal-nerve-stimulation-in-the-treatment-of-patients-with-rheumatoid-arthritis-our-results-through-day-84-of-the-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-204.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/musculosceletal-ultrasound-in-monitoring-efficacy-of-intraarticular-infliximab-therapy-in-juvenile-idiopathic-arthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-205.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/musculosceletal-ultrasound-in-monitoring-efficacy-of-intraarticular-infliximab-therapy-in-juvenile-idiopathic-arthritis-patients-362/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/musculosceletal-ultrasound-in-monitoring-efficacy-of-intraarticular-infliximab-therapy-in-juvenile-idiopathic-arthritis-patients-363/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/probiotic-vsl-3-as-adjuvant-therapy-in-patients-with-undifferentiated-spondyloartrhritis/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/probiotic-vsl-3-as-adjuvant-therapy-in-patients-with-undifferentiated-spondyloartrhritis-365/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-209.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/musculoskeletal-ultrasound-of-hands-and-feet-in-patients-with-seropositive-polyarthralgias-possible-role-in-changing-of-treatment-decision/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-210.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-fifty-male-psoriatic-monoarthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-211.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-fifty-male-psoriatic-monoarthritis-patients-368/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-fifty-male-psoriatic-monoarthritis-patients-369/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/qualitative-analysis-of-digitopalmar-dermatoglyphics-in-fi-fty-female-symmetric-psoriatic-polyarthrits-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-214.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/qualitative-analysis-of-digitopalmar-dermatoglyphics-in-fifty-male-psoriatic-spondylitis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-215.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-twenty-female-reactive-spondyloarthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-216.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/mortons-metatarsalgia-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-217.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/effect-of-biomagnetotherapy-on-pain-and-function-in-patients-with-hand-osteoarthritis/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/effect-of-biomagnetotherapy-on-pain-and-function-in-patients-with-hand-osteoarthritis-375/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-219.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/sarcoidosis-and-acute-renal-failure-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-220.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/aims-and-patients-expectation-from-the-outpatient-visit-to-rheumatologist/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-221.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/adherence-to-treatment-recommendations/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/adherence-to-treatment-recommendations-379/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/adherence-to-treatment-recommendations-380/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-224.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/patients-preparation-and-expectation-from-the-outpatient-visit-to-rheumatologist-and-adherence-to-recommendations-and-instructions-for-treatment-a-personal-perspective/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-225.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/adherence-to-recommendations-and-instructions-for-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-226.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/patients-preparations-and-expectations-from-the-outpatient-visit-to-rheumatologist/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2013/2/patients-preparations-and-expectations-from-the-outpatient-visit-to-rheumatologist-384/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-228.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/adherence-to-recommendations-and-instructions-for-treatment-perspective-of-a-patient-with-sclerodermia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-229.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/expectations-from-the-outpatient-visit-to-rheumatologist-doctors-view/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-230.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/living-with-rheumatoid-arthritis-new-brochure-for-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-231.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/survey-joint-to-fight-against-ra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-232.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/biologic-monotherapy-effective-and-safe-way-of-rheumatoid-arthritis-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-233.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/leadership-trough-rounds/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-234.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/teamwork-in-health-care/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-235.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/how-can-motivational-interview-help/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-236.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/the-significance-of-alimentation-in-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-237.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/medical-care-of-vasculitis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-238.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/medical-care-in-vasculitis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-239.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/vasculitis-in-patients-treated-at-the-department-of-rheumatology-and-clinical-immunology-of-the-clinical-hospital-centre-split-from-january-2010-till-june-2013/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-240.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/vasculitis-allergica-leukocytoclastica-nurses-role/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-241.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/extraarticular-rheumatism/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-242.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/the-frequency-of-respiratory-difficulties-in-persons-with-disabilities/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-243.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/painful-shoulder-or-translated-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-244.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/complex-regional-pain-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-245.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/calcifying-tendinophaties-of-the-shoulder-eff-ectiveness-of-eswt/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-246.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/mobilisation-of-shoulder-joint-in-the-extraarticular-rheumatism-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-247.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/physiotherapy-procedures-in-patients-with-lateral-epicondylitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-248.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/antistress-workshop/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-249.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/secondary-prevention-of-osteoporotic-fractures-and-osteoanabolic-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-250.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/rituximab-in-treatment-of-anca-vasculitides-from-clinical-studies-to-clinical-application/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-251.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/early-remission/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-252.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/different-options-in-treatment-of-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-253.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/a-view-to-the-ra-treatment-safety-profile-what-will-the-data-on-long-term-biologics-application-bring/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-254.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/febuxostat/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-255.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/retrospective-analysis-of-golimumab-treatment-in-patients-with-inflammatory-rheumatic-diseases-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-256.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/risbon-risedronate-of-a-novel-monthly-dosing-regiment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-257.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/alfacalcidol-alpha-d3-a-novel-agent-in-treatment-of-patients-with-vitamin-d-defi-ciency-and-osteoporosis-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-258.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/a-review-on-ibuprofen/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-259.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/sixty-years-of-reumatizam/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-260.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/on-the-occasion-of-85th-anniversary-of-therapy-and-75th-anniversary-of-central-rheuma-station-in-zagreb/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-272.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1003.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1004.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/programme-fifteenth-annual-congress-of-the-croatian-society-for-rheumatology-of-the-cma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1005.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/programme-meeting-of-patients-associations-representatives/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1006.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/programme-24th-education-course-for-nurses-and-physiotherapists/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1007.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/classification-of-vasculitides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1008.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/asas-health-index-translation-to-croatian-language-and-preliminary-results-of-developing-an-instrument-specific-for-axial-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1009.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/the-use-of-petct-in-assessment-of-periaortitis-treatment-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1010.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1011.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/the-effect-of-low-dose-methotrexate-on-bone-mineral-density-in-premenopausal-women-with-early-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-1012.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-1013.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-1014.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/relationship-between-vitamin-d-status-and-bone-mineral-density-in-croatian-postmenopausal-women/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-8.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/inflammatory-bowel-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-13.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/the-existence-of-geographical-clusters-of-rheumatiod-arhritis-according-to-their-origin-in-a-tertiary-care-based-register/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-14.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/course-and-prognosis-in-seropositive-and-seronegative-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-19.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/antisynthetase-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-25.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/paraneoplastic-hypertrophic-osteoarthropathy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-29.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/the-most-frequent-childhood-vasculitides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-30.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/gluten-sensitive-enteropathy-a-disease-to-take-into-consideration-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-32.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/large-vessel-vasculitides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-35.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/eosinophilic-fasciitis-associated-with-parkinsons-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-37.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/laboratory-diagnostics-of-anca-vasculitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-39.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/changes-in-social-relations-as-a-consequence-of-rheumatoid-arthritis-and-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-42.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/anti-neutrophil-cytoplasmic-antibodies-anca-associated-vasculitides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-43.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/treatment-of-vasculitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-47.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/the-proposal-of-the-croatian-society-for-rheumatology-for-the-treatment-of-adult-rheumatoid-arthritis-patients-with-biologics-2013/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-47.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/the-proposal-of-croatian-society-for-rheumatology-for-anti-tnf-therapy-in-adult-patients-with-spondyloarthritides-2013/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-52.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/tendinopathy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-55.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/1/guidelines-on-biologic-drugs-for-the-treatment-of-children-with-juvenile-idiopathic-arthritis-jia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/1/reumatizam-60-57.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/the-most-common-entities-of-localised-extraarticular-rheumatism/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-60.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/complex-regional-pain-syndrome-pathophysiology-clinical-presentation-and-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-67.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/myofascial-pain-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-81.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2013/2/principles-of-extra-articular-rheumatic-diseases-treatment-therapeutic-dilemmas-and-treatment-algorithms/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2013/2/reumatizam-60-84.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-fifty-male-psoriatic-spondylitis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-290.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/osteoarthritic-temporomandibular-joint-changes-confirmed-by-magnetic-resonance-imaging/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-291.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/the-influence-of-corticosteroid-therapy-on-development-of-osteoporosis-in-crohns-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-292.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/the-influence-of-corticosteroid-therapy-on-development-of-osteoporosis-in-crohns-disease-450/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-293.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/vaccination-in-chronic-autoimmune-and-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-294.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/treatment-of-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-295.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/a-glagolitic-prayer-against-gout-from-the-early-19th-century/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-296.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/acute-renal-failure-in-a-patient-with-congenital-myopathy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-328.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/calcynosis-in-two-adult-female-patients-with-dermatomyosytis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-329.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/successful-treatment-of-focal-myositis-of-tibia-using-botulinum-toxin-a-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-330.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/rosuvastatin-induced-acute-inflammatory-disorder-with-myositis-and-hepatitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-331.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/polymyosytis-and-rheumatoid-arthritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-332.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/high-level-of-alarmin-hmgb-1-together-with-low-level-of-its-soluble-receptor-srage-in-juvenile-systemic-erytemic-lupus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-333.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/high-level-of-kreatine-kynase-in-rheumathology-practice/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-334.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/eosinophilia-myalgia-syndrome-induced-by-excessive-l-triptophan-intake-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-335.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/ultrasound-in-diagnosis-and-follow-up-of-dermatomyositis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-336.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/unilateral-septic-sacroileitis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-337.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/do-we-follow-asas-criteria-for-diagnosis-of-axial-spondiloartritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-338.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/gigantocelular-vasculitis-diagnostic-dilemmas-and-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-339.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/raynaud-phenomena-as-first-sign-of-malignant-disease-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-340.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/the-education-workshops-efficacy-of-bamboo-project/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-341.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/biologic-therapy-of-inflammatory-rheumatic-diseases-6-year-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-342.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/pulmonary-fibrosis-in-rheumatoid-arthritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-343.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/naphthalan-oil-in-the-treatment-of-psoriasis-and-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-344.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/haemolytic-uraemic-syndrome-and-systemic-lupus-erythematosus-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-345.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/churg-strauss-syndrome-associated-with-montelukast-therapy-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-346.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/arthritis-in-celiac-disease-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-347.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/q10-coenzyme-treatment-in-fibromyalgia-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-348.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/is-there-an-association-between-tuberculosis-and-cervical-cancer-a-case-report-on-a-patient-with-tuberculous-monoarthritis-of-knee-joint/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-349.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/gout-prevalence-in-physiatric-and-general-practice/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-350.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/hyperuricaemia-cardiovascular-risk-factor/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-351.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/ultrasonographic-detection-of-urate-and-calcium-pyrophosphate-crystals-deposits-in-a-patient-with-normal-serum-urate-concentration-and-a-history-of-acute-crystal-arthritis-of-the-foot-and-knee-osteoar/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-352.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/recognition-and-treatment-of-patients-with-spondylarhritides-survey-of-croatian-rheumatologists/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-353.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/dissimulation-of-rheumatic-complaints-public-health-problem/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-354.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-fifty-female-patients-with-psoriatic-monoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-355.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/quantitative-analysis-of-digitopalmar-dermatoglyphycs-in-forty-male-patients-with-reactive-spondyloarthritis-reiters-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-356.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/evaluation-of-potential-functional-parameters-based-on-dynamic-hand-elektrodinamometric-measurements-edm-with-new-dynamis-system/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-357.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/review-of-ultrasound-findings-and-the-efficacy-of-physical-therapy-in-patients-with-sprained-ankle/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-358.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/physical-treatment-and-ketoprofen-gel-use-for-temporomandibular-joint-disorder-confirmed-by-magnetic-resonance-imaging/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-359.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/the-ratio-of-recommended-and-prescribed-osteoporosis-medications/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-360.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/densitometry-in-patients-on-chronic-hemodyalisis-in-general-hospital-virovitica/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-361.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/bone-mineral-density-and-low-estrogen-levels-in-menopausal-and-postmenopausal-females/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-362.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/physical-performance-and-correlation-with-vitamin-d-status-in-croatian-postmenopausal-women/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-363.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/biological-therapy-in-juvenile-idiopathic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-364.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/psychologic-and-psychiatric-aspects-of-chronic-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-386.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/life-quality-and-chronic-musculo-skeletal-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-387.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/the-importance-of-patient-associations-for-illness-acceptance-socializing-and-laughter-are-the-best-pain-relief/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-388.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/chronic-pain-and-cognitive-bihevioral-techniques-a-personal-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-389.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/psycological-aspects-of-chronic-pain-a-patients-view/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-390.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/cognitive-bihevioral-techniques-and-chronic-pain-workshop/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-391.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/epidemiology-patophysiology-and-treatment-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-392.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/the-effect-of-strontium-ranelate-in-knee-osteoarthritis-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-393.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/biological-monotherapy-treatment-what-it-means-for-doctors-and-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-394.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/multi-year-efficacy-and-safety-of-rituximab/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-395.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/calcium-and-vitamine-d-suplementation-for-healty-bones/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-396.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-1015.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-1016.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/programme-fourteenth-annual-congress-of-the-croatian-society-for-rheumatology-of-the-cma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-1017.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/programme-23rd-education-course/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-1018.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/programme-meeting-of-patients-associations-representatives/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-1019.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-forty-male-patients-with-primary-hypertrophic-osteoartropathy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-1020.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-1021.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-1022.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-1023.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/1/scoring-of-disease-activity-using-basdai-and-asdas-method-in-ankylosing-spondylitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/1/reumatizam-59-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/fatty-tissue-and-bone/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-13.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/pathogenesis-of-polymyositis-and-dermatomyositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-23.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/laboratory-diagnostics-of-polymyositisdermatomyositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-27.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/electromyoneurographic-study-in-inflammatory-and-noninflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-31.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/pathology-diagnosis-of-idiopathic-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-35.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/non-invasive-imaging-of-chronic-inflammatory-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-39.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/polymyositisdermatomyositis-clinical-picture-and-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-44.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/polymyositis-dematomyositis-overlap-syndromes-with-connective-tissue-diseases-and-malignancies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-51.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/anti-synthetase-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-53.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/rare-myositides-and-myopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-58.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/juvenile-dermatomyositis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-63.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/exercises-in-patients-with-myositis-active-treatment-intervention/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-73.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/uric-arthritis-a-hystorical-view/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-77.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/epidemiology-and-risk-factors-for-gout/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-82.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/pathophysiology-of-gout/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-89.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/clinical-features-and-laboratory-diagnostics-of-uric-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-93.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/radiologic-imaging-of-crystalline-arthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-97.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/conventional-treatment-of-gout/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-105.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/new-and-emerging-drugs-for-uric-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-110.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/gout-as-a-systemic-disease-systemic-manifestations-and-comorbidities-of-hyperuricaemia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-119.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/pseudo-gout/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-133.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/musculoskeletal-ultrasound-in-rheumatology-current-status-and-future-perspectives/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-136.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2012/2/role-of-diagnostic-ultrasound-in-assessment-of-disease-activity-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2012/2/reumatizam-59-140.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/the-role-of-anti-cyclic-citrullinated-peptide-antibodies-in-predicting-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-397.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/the-effect-of-physical-theraphy-on-the-most-severe-forms-of-knee-structral-changes-caused-by-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-398.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/the-relevance-of-muscle-strength-extensors-of-the-knee-on-pain-relief-in-elderly-people-with-knee-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-399.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/abstract/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2011/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1024.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1025.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/programme-thirteenth-annual-congress-of-the-croatian-society-for-rheumatology-of-the-cma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1026.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/programme-meeting-of-patients-associations-representatives/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1027.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/programme-22nd-education-course-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1028.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/thermography-and-infrared-image-analysis-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1029.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/functional-evaluation-of-low-back-pain-using-modified-oswestri-questionnaire/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1030.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/low-back-pain-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1031.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/review-of-ultrasound-findings-in-patients-with-shoulder-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1032.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/gene-expression-in-juvenile-spondyloarthritides-possible-connection-with-autoinflammatory-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1033.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/reduced-osteoblastogenesis-of-synovial-precursor-cells-indicator-of-systemic-inflammation-in-juvenile-idiopathic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1034.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/imunological-and-clinical-characteristics-of-nodous-polyartheritis-in-children-20-year-retrospective-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1035.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/calcaneal-osteomyelitis-in-10-year-old-boy-with-calcaneal-apophysitis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1036.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/severe-form-of-juvenile-idiopathic-arthritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1037.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/adult-onset-stills-disease-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1038.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/ankylosing-spondylitis-and-vertebral-hemangioma-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1039.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-differential-diagnosis-of-seronegative-spondilarthrytis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1040.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/scoring-of-disease-activity-using-basdai-and-asdas-method-in-ankylosing-spondylitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1041.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/depression-in-rheumatoid-arthritis-and-ankylosing-spondylitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1042.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/diastolic-dysfunction-in-patients-with-rheumatoid-arthritis-relation-to-disease-activity-and-anti-cyclic-citrullinated-peptide-antibodies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1043.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/ultrasound-and-magnetic-resonance-imaging-in-early-rheumatoid-arthritis-changes-of-shoulder-joint/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1044.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/rapid3-index-test-significantly-corelates-with-rheumathoid-arthritis-activity/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1045.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/physicians-global-assessment-of-disease-activity-of-rheumathoid-arthritis-what-is-it-based-on/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1046.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/pain-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1047.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/fatigue-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1048.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/depression-and-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1049.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/life-quality-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1050.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/rheumatoid-arthritis-and-primary-billiary-cirrhosis-treatment-with-tnf-blockers-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1051.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/comparison-in-treatment-of-rheumatoid-arthritis-with-methotrexate-alone-and-methotrexate-combined-with-etanercept/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1052.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/cessation-and-reintroduction-of-the-same-biologic-therapy-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1053.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/acute-phlegmonous-appendicitis-a-treatment-complication-in-a-rheumatoid-arthritis-patient-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1054.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/do-we-implement-the-principle-of-treating-ra-to-target-in-practice/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1055.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-twenty-male-patients-with-psoriatic-arthritis-mutilans/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1056.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-twenty-female-patients-with-psoriatic-oligoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1057.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-twenty-male-patients-with-psoriatic-oligoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1058.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/avascular-aseptic-necrosis-of-the-femoral-head-in-two-female-patients-with-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1059.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/tumor-frequency-in-systemic-lupus-erythematosus-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1060.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/epidemiological-characteristics-of-progressive-systemic-sclerosis-in-eastern-part-of-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1061.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/acute-renal-insufficiency-in-sclerodermia-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1062.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/is-helicobacter-pylori-infection-a-risk-factor-for-disease-severity-in-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1063.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/bone-metabolism-in-mixed-connective-tissue-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1064.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/petct-in-evaluation-of-fever-of-unknown-cause-female-patient-with-giant-vessels-vasculitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1065.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/wegeners-granulomatosis-of-the-upper-respiratory-tract-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1066.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/diagnostic-and-therapeutic-challenges-in-patient-with-cerebral-demyelination-and-cytomegalovirus-infection-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1067.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/idiopatic-eosinophylic-pleural-effusion-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1068.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/hemofagocitic-lymphohystiocitosis-hemofagocitic-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1069.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/osteitis-mandibulae-in-sapho-syndrome-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1070.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/charcot-neuroarthropathy-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1071.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/various-rheumatic-diseases-in-patients-with-temporomandibular-joint-disorder/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1072.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/skin-diseases-frequency-in-physiatric-outpatient-clinic/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1073.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/physical-medicine-and-rehabilitation-service-in-public-and-private-institutions/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1074.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/female-patient-with-isolated-elbow-contracture-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1075.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/bifid-median-nerve-in-a-young-patient-with-carpal-tunnel-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1076.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/osteoporosis-treatment-in-female-patients-before-proximal-femur-fracture-surgery/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1077.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-twenty-female-patients-with-psoriatic-arthritis-mutilans/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1078.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-twenty-male-patients-with-symmetrical-psoriatic-polyarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1079.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-twenty-female-patients-with-psoriatic-spondylits/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1080.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/musculoskeletal-manifestations-in-lysosomal-storage-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1081.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/denosumab-rank-ligand-inhibition-from-clinical-studies-to-clinical-application/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1082.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/golimumab-simponitm-the-first-subcutaneous-anti-tnf-drug-for-ra-onefold-month-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1083.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-safety-of-rituximab-mabthera-treatment-in-rheumatoid-arthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1084.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-effect-of-methotrexate-treatment-on-cardiovascular-comorbidity-in-rheumatoid-arthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1085.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/optimising-clinical-outcomes-with-subcutaneous-methotrexate-in-the-management-of-patients-with-ra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1086.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-1087.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-1088.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-1089.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/the-connection-between-hla-microsatellites-and-hla-b27-gene-in-patients-with-psoriatic-arthritis-in-croatian-population/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/the-role-of-anti-cyclic-citrullinated-peptide-antibodies-in-predicting-rheumatoid-arthritis-562/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-12.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/eye-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-13.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/the-effect-of-physical-theraphy-on-the-most-severe-forms-of-knee-structral-changes-caused-by-osteoarthritis-564/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-15.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/the-relevance-of-muscle-strength-extensors-of-the-knee-on-pain-relief-in-elderly-people-with-knee-osteoarthritis-565/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-21.pdf 2026-07-16 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/epidemiology-of-spondylarthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-24.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/1/international-classification-of-functioning-disability-and-health-icf-in-the-most-important-diseases-and-conditions-of-rheumatology-practice/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/1/reumatizam-58-27.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/etiology-and-pathogenesis-of-spondyloarthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-36.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-classification-of-spondyloarthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-39.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-classification-of-juvenile-spondyloarthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-44.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-early-diagnosis-of-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-47.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/spondyloarthritides-clinical-features/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-51.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/extra-articular-manifestations-of-seronegative-spondyloarthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-54.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/imaging-in-diagnostics-of-spondylartrhitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-57.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-role-of-magnetic-resonance-imaging-in-seronegative-spondyloarthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-61.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-pharmacotherapy-of-spondyloarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-65.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/nonpharmacological-treatment-of-patients-with-spondyloarthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-69.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/ultrasonographic-semiology-correlation-between-anatomy-and-sonography-of-musculoskeletal-tissue/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-85.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-value-of-sonography-and-power-doppler-in-the-detection-of-early-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-94.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/low-back-pain-from-definition-to-diagnosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-105.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/low-back-pain-vs-leg-dominant-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-108.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/an-overview-of-conservative-treatment-for-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-112.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/the-role-of-rehabilitation-in-the-treatment-of-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-120.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2011/2/what-a-rheumatologist-must-know-about-spine-surgery/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2011/2/reumatizam-58-124.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1090.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1091.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/programme-twelfth-annual-congress-of-the-croatian-society-for-rheumatology-of-the-cma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1092.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/comparison-of-the-effectiveness-of-therapeutic-exercise-on-dry-land-and-exercises-in-the-water-on-the-degree-of-pain-and-disability-due-to-pain-in-patients-with-chronic-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1093.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/delayed-onset-of-muscle-soreness-orand-balneoreaction/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1094.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/naphtalan-treatment-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1095.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/manual-medicine-in-the-upper-motor-neuron-lesion-treatment-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1096.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/review-of-ultrasound-findings-and-the-effectiveness-of-physical-therapy-in-patients-with-painful-shoulder-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1097.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/progressive-systemic-sclerosis-continuous-diagnostic-challenge-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1098.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/eradication-of-helicobacter-pylory-infection-may-reduce-activity-of-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1099.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/interstitial-pulmonary-disease-in-systemic-sclerosis-our-experiences/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1100.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/clinical-manifestations-of-progressive-systemic-sclerosis-in-kosova/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1101.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/radiographic-findings-in-seropositive-and-seronegative-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1102.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/cervical-spine-changes-in-rheumatoid-artritis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1103.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/rheumatoid-arthritis-and-myocardial-infarction-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1104.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/emotional-reactions-in-rheumatoid-artritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1105.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/adult-still-disease-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1106.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/hla-mycrosatelites-d6s248-d6s2674-d6s2811-d6s273-and-hla-b27-gene-in-etiopatogenesis-of-psoriatic-arthritis-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1107.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-fifty-male-psoriatic-spondylitis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1108.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/chronic-recurent-multifocal-osteomyelitis-in-12-year-old-boy-diagnosed-by-18fdg-petct-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1109.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/combined-ankylosing-spondylitis-and-uric-arthritis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1110.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/eosinophylic-fasciitis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1111.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/problems-of-rheumatic-patient-in-prosthetic-rehabilitation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1112.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/chronic-vertebral-pain-seen-through-international-classification-of-functioning-disability-and-health/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1113.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/physicomedical-therapy-and-topical-ketoprofen-for-temporomandibular-joint-disorder-at-least-12-month-follow-up/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1114.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/chondromatosis-of-temporomandibular-joint-a-case-report-with-a-literature-review/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1115.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/intravenous-osteoporosis-treatment-densitometry-standard-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1116.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/work-treated-stress-among-croatian-policlinical-healthcare-workers/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1117.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/comparison-of-nonpharmacologic-treatment-of-polyneuropathy-in-rheumatic-diseases-and-diabetes/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1118.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/cervicobrachial-syndrome-in-boreliosis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1119.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/why-do-we-need-registries-of-patients-on-biologics-drugs/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1120.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/golimumab-simponi-first-subcutaneous-anti-tnf-with-once-monthly-application/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1121.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/optimizing-rheumatoid-arthritis-treatment-with-rituximab-individualized-patient-approach/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1122.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/safety-of-rituximab-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1123.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/treatment-of-rheumatoid-and-psoriatic-arthritis-review-of-leflunomide/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1124.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/topical-treatment-with-diclofenac-with-improved-effect-diclo-duo-spray/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1125.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/patients-opinions-and-knowledge-about-osteoporosis-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1126.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-1127.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-1128.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-1129.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/biomarkers-in-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/laboratory-examination-of-seronegative-and-seropositive-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-10.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/cardiovascular-diseases-and-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-11.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/physical-therapy-in-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-16.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/dermatoglyphics-in-psoriatic-symmetrical-polyarthritis-in-fifty-women-quantitative-analysis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-17.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/functional-status-of-patients-after-lumbar-disc-herniation-surgery/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-21.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/non-pharmacologic-treatment-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-22.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/physical-therapy-in-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-26.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/nonsteroidal-anti-inflammatory-drugs-and-the-risk-of-cardiovascular-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-26.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/proposal-for-biologic-drugs-therapy-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-29.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/spondyloarthritides-principles-of-rehabilitation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-31.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/guidelines-of-the-croatian-society-for-rheumatology-for-the-treatment-of-knee-and-hip-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-36.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/the-international-classification-of-functioning-disability-and-health-icf-and-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-39.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/1/benign-joint-hypermobility-syndrome-a-case-report-unrecognized-or-undiagnosed-condition/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/1/reumatizam-57-48.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/ultrasonography-in-locomotor-system-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-50.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/standardised-ultrasound-scanning-of-the-shoulder-normal-and-basic-pathological-findings/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-54.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/standardised-ultrasound-scanning-of-the-elbow/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-62.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/diagnostic-ultrasound-of-the-small-joints-of-the-hands-and-feet-current-status-and-role-of-ultrasound-in-early-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-68.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/ultrasonography-of-the-hip-knee-and-ankle/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-81.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/systemic-sclerosis-introductory-lecture/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-90.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/incidence-prevalence-and-disease-characteristics-of-systemic-sclerosis-in-split-dalmatia-county/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-94.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/heart-involvement-and-pulmonary-arterial-hypertension-in-patients-with-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-99.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/interstitial-lung-disease-ild-in-systemic-sclerosis-ssc/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-105.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/scleroderma-renal-crisis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-109.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/gastrointestinal-changes-in-patients-with-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-112.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/digital-ulcers-in-systemic-sclerosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-115.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/clinical-characteristics-of-scleroderma-like-disorders/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-118.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2010/2/capillaroscopy-as-a-prognostic-tool-for-the-development-of-connective-tissue-disease-in-patients-with-raynauds-phenomenon/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2010/2/reumatizam-57-119.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1130.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1131.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/programme-eleventh-annual-congress-of-the-croatian-society-for-rheumatology-of-the-cma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1132.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/extra-articular-manifestations-in-seronegative-and-seropositive-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1133.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/comparison-of-ultrasound-and-mri-findings-of-hands-in-polyarthritises-that-do-not-fulfill-ara-criteia-for-diagnosis-of-rheumatod-arthritis-ra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1134.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/quantitative-analysis-of-digitopalmar-dermatoglyphics-in-50-male-patients-with-psoriatic-spondylitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1135.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/the-assessment-of-functional-condition-of-patients-with-hip-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1136.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/the-significance-of-knee-extensors-strength-on-pain-relief-in-elderly-with-knee-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1137.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/comparison-of-ultrasonography-with-magnetic-resonance-imaging-in-the-diagnosis-of-temporomandibular-joint-effusion-literature-review-with-a-clinical-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1138.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/hyperuricaemia-and-gout-in-elderly/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1139.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/therapy-of-osteoarthritis-of-the-temporomandibular-joint-during-8-months-two-case-reports/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1140.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/conservative-treatment-of-low-back-pain-caused-by-disc-hernia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1141.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/the-osteoporosis-treatment-in-gastrectomised-patient/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1142.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/the-effect-of-obesity-on-the-risk-of-compression-vertebral-fractures-in-patients-with-postmenopausal-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1143.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/optimisation-of-alendronate-efficacy-by-integration-of-cholecalciferole-into-weekly-drug-formulation-fosavance-5600/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1144.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/bisphosphonates-specifics-of-risedronate-and-advantages-of-the-new-unique-packaging-actonel-combi-d/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-1145.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-1146.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-1147.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/meetings/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-1148.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/corrections/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-1149.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/the-clinical-picture-of-rheumatoid-arthritis-the-complex-of-three-independent-mechanisms/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/comparison-of-seronegative-and-seropositive-rheumatoid-arthritis-with-regard-to-some-clinical-characteristics/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-8.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/the-history-of-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-9.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-16.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/the-diversity-of-extended-gen-haplotypes-hla-b27-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-17.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/clinical-significance-of-antinuclear-antibodies-and-other-serological-abnormalities-in-systemic-lupus-erythematosus-sle/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-22.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/dermatoglyphics-of-digitopalmar-complex-in-forty-male-patients-affected-by-rheumatoid-arthritis-quantitative-analysis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-25.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/systemic-lupus-erythematosus-and-the-complement-system/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-26.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/neuropsychiatric-manifestations-of-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-29.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/renal-involvement-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-30.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/lupus-nephritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-34.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/arthritis-in-paraneoplastic-syndrome-a-way-to-early-cancer-diagnosis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-36.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/hormonal-therapy-in-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-41.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/1/capillaroscopy-an-insufficiently-known-and-underused-method-in-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/1/reumatizam-56-41.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/mortality-characteristics-in-people-with-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-44.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/the-reliability-and-validity-of-a-croatian-version-of-the-bath-ankylosing-spondylitis-functional-index-basfi-and-bath-ankylosing-spondylitis-disease-activity-index-basdai-in-patients-with-ankylosing-s/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-63.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/the-effects-of-combined-therapy-of-rheumatoid-arthritis-on-the-acute-phase-reactants/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-77.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2009/2/diagnostic-imaging-in-assessment-of-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2009/2/reumatizam-56-81.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/treatment-strategy-for-rheumatoid-arthritis-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-513.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/10th-annual-congress-of-the-croatian-society-for-rheumatology/ 2026-07-16 monthly 0.8 https://www.reumatizam.abol.hr/articles/2008/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1150.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1151.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/programme-tenth-annual-congress-of-the-croatian-society-for-rheumatology-of-the-cma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1152.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/the-value-of-ultrasound-in-monitoring-and-differential-diagnosis-of-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1153.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/the-efficacy-of-anti-tnf-therapy-in-treatment-of-juvenile-idiopathic-arthritis-eight-years-of-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1154.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/biological-treatment-of-rheumatoid-arthritis-our-experiences/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1155.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/the-safety-of-biologic-therapy-in-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1156.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/serous-meningitis-in-ra-patient-treated-with-adalimumab-sulfasalazine-ketoprofen-and-low-dose-metilprednisolone/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1157.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/the-influence-of-functional-changes-and-depression-on-social-contacts-of-patients-with-rheumatoid-artrhritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1158.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/the-comparison-of-clinical-characteristics-of-seronegative-and-seropositive-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1159.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/etanercept-treatment-in-patient-with-active-ankylosing-spondylitis-and-hepatic-lesion-nash-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1160.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/polymyalgia-rheumatica-and-arteritis-gigantocelularis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1161.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/typical-polymyalgia-rheumatica-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1162.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/polymyalgia-rheumatica-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1163.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/bilateral-spontaneous-rupture-of-achilles-tendon-in-a-patient-with-psoriatic-arthritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1164.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/neuropsychiatric-systemic-lupus-erythematosus-diagnostic-and-clinical-features/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1165.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/atherosclerosis-in-patients-with-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1166.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/osteoarthritis-of-temporomandibular-joint-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1167.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/influence-of-exercises-on-right-and-left-thigh-circumference-in-knee-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1168.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/coincidence-of-clinical-and-ultrasound-findings-in-periarthritis-humeroscapularis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1169.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/diferential-diagnosis-of-periarthritis-humeroscapularis-by-ultrasound/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1170.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/medical-prognosis-of-working-ability-in-patients-with-chronic-regional-pain-syndrome-of-hand/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1171.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/poststreptococcal-reactive-arthritis-in-adults/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1172.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/heerfordt-waldenstrom-syndrome-in-patient-with-left-temporomandibular-joint-pain-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1173.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/is-there-a-correlation-among-chronic-neck-pain-function-and-radiological-findings/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1174.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/knee-osteoarthritis-with-regard-to-some-risk-factors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1175.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/diferential-dijagnostics-between-reiters-disease-and-psoriatic-spondylitis-in-men-using-quantitative-dermatoglyphic-analysis-of-digitopalmar-complex/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1176.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/avascular-necrosis-of-the-femoral-head-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1177.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/crest-syndrome-treatment-challenges/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1178.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/biologic-therapy-in-rheumatoid-arthritis-real-possibilities-of-full-remission/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1179.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/ibandronate-bonviva-iv-the-first-bisphosphonate-in-quartal-application/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1180.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/alendronate-and-vitamin-d-fosavance-in-postmenopausal-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1181.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/vitamin-d-for-strong-bones/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1182.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/nonsteroidal-antirheumatic-drugs-balance-between-gastrointestinal-and-cardiovascular-side-effects/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1183.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-1184.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-1185.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-1186.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/haplotipic-associations-of-the-two-most-common-hla-b27-alleles-in-the-croatian-population/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/diagnostic-and-therapeutic-approach-to-pregnant-women-suspect-on-antiphospholipid-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-10.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/from-the-history-of-the-croatian-society-for-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-11.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/anticonvulsant-induced-metabolic-disorder-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-16.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/aterosklerotske-promjene-krvnih-sudova-glave-i-vrata-u-bolesnika-sa-sistemskim-eritemskim-lupusom/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-19.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/proposal-for-anti-tnf-therapy-in-adult-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-22.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/early-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-26.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/recommendations-of-the-croatian-society-for-rheumatology-for-prevention-diagnostics-and-treatment-of-post-menopausal-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-26.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/1/diagnostics-of-latent-tuberculosis-tb-in-adult-vaccinated-patients-bcg-in-croatia-before-introduction-of-tumor-necrosis-factor-antagonist-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/1/reumatizam-55-31.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/rheumatoid-arthritis-new-imaging-methods/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-34.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/monitoring-disease-activity-adjustment-of-conventional-treatment-and-prognosis-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-45.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/cardiovascular-disorders-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-53.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/polymyalgia-rheumatica/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-57.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/stabile-remission-of-early-active-rheumatoid-arthritis-treated-with-etanercept-enbrel/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-60.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/adalimumab-humira-efficacy-in-rheumatoid-arthritis-treatment-with-particular-reference-to-working-ability/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-62.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/the-efficacy-and-safety-of-the-combination-of-leflunomide-arava-and-biological-agents-in-treatment-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-68.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/rituximab-mabthera-treatment-of-rheumatoid-arthritis-patients-with-inadequate-response-to-tnf-inhibitors-when-to-change-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-70.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/strontium-ranelates-osseor-dual-mode-of-action-increasing-bone-mass-and-decreasing-bone-resorption/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-73.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/the-efficacy-of-strontium-ranelate-osseor-on-fractures-in-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-75.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/differences-among-bisfosfonates-specificity-of-risedronate-actonel/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-78.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/diclofenac-of-rapid-effect-diclorapid-with-better-gastric-tolerability/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-81.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2008/2/meloxicam-the-balance-of-efficacy-and-safety/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2008/2/reumatizam-55-85.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-diagnostic-value-of-anti-ccp-antibodies-in-rheumatoid-arthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-569.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/topoisomerase-i-serological-marker-of-digital-joint-contractures-progression-in-systemic-sclerosis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-570.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/differential-diagnostics-between-psoriatic-and-ankylosing-spondylitis-in-men-using-quantitative-dermatoglyphic-analysis-of-digitgopalmar-complex/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-571.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-evaluation-of-early-diagnostic-value-of-arthrosonography-of-the-hands-in-patients-with-rheumatic-symptoms/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-572.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/osteoarthritis-of-temporomandibular-joint-clinical-and-radiological-diagnostics/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-573.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-effect-of-stabilisation-exercises-on-pain-and-patients-general-functional-status/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-574.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-role-of-physical-therapy-in-treatment-of-severe-forms-of-osteoarthritis-of-knee/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-575.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/analgetic-effect-of-pulsed-electromagnetic-fields-in-patients-with-knee-osteoarthritis-pilot-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-576.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/manual-therapy-and-intramuscular-stimulation-in-chronic-pain-treatment-of-musculoskeletal-system/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-577.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/our-experiences-in-ultrasound-controlled-application-of-local-infiltrations-in-musculoskeletal-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-578.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/experiences-with-buprenorfine-transtec-in-treatment-of-musculoskeletal-pain-in-dispensary-for-pain-in-barcelona/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-579.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/treatment-of-rheumatoid-arthritis-using-combined-therapy-with-metotrexate/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-580.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/most-frequent-side-effects-of-anti-tnf-therapy-our-experience/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-581.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/patients-preference-for-monthly-bisphosphonate-preliminary-results-of-promo-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-582.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-influence-of-an-important-media-event-on-the-increase-in-number-of-medical-examinations-of-shoulder/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-583.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/coexistence-of-systemic-lupus-erythematosus-and-psoriasis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-584.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/overlap-of-ankylosing-spondylitis-and-psoriatic-arthritis-in-a-patient-with-psoriasis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-585.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/ankylosing-spondylitis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-586.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/avascular-necrosis-of-bone-and-multifocal-osteomyelitis-in-a-young-female-patient-with-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-587.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-1187.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-1188.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/programme-ninth-annual-congress-of-the-croatian-society-for-rheumatology-of-the-cma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-1189.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/pain-intensity-in-osteoarthritis-polyarthritis-and-spondylarthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-1190.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-1191.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/1/reumatizam-54-1192.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/1/reumatizam-54-1193.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/1/comparative-analysis-of-seronegative-and-seropositive-rheumatoid-arthritis-regarding-some-epidemiological-and-anamnestic-characteristics/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/1/reumatizam-54-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/pediatric-rheumatic-diseases-per-aspera-ad-astra/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-11.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/1/the-cervical-spine-involvement-in-patients-with-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/1/reumatizam-54-12.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/1/proposal-for-anti-tnf-therapy-in-adult-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/1/reumatizam-54-16.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/1/proposal-of-croatian-society-for-rheumatology-for-anti-tnf-therapy-in-adult-patients-with-spondyloarthritides/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/1/reumatizam-54-20.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-pain-epidemiology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-24.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-pathophysiology-of-chronic-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-28.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-diagnostics-of-chronic-musculoskeletal-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-32.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/non-pharmacological-treatment-of-musculoskeletal-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-37.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/pharmacotherapy-of-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-49.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/tuberculosis-and-anti-tnf-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-54.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/immunosupression-and-viral-infections-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-58.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-treatment-of-febrile-immunosuppressed-patient/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-63.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/leflunomide-arava-in-the-treatment-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-67.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/etanercept-enbrel-our-experiences/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-69.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-role-of-b-lymphocytes-in-pathogenesis-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-71.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/rituximab-mabthera-new-approach-in-treatment-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-72.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/it-is-time-for-opioids/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-74.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/new-hyaluronan-suplasyn-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-75.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/rational-pharmacotherapeutic-pain-treatment-in-seronegative-spondyloarthropathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-77.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/meloxicam-movalis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-81.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/strontium-ranelate-osseor-unique-double-mechanism-physiologic-bone-treatment-as-live-tissue/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-83.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/risedronate-actonel-from-randomized-clinical-trials-to-real-life/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-85.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/does-ibandronate-bonviva-have-an-impact-on-non-vertebral-fractures/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-87.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/alendronate-and-vitamin-d-fosavance-persistence-adherence-and-importance-of-vitamin-d/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-89.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2007/2/the-influence-of-teriparatide-forteo-on-low-back-pain-incidence-in-postmenopausal-osteoporotic-woman/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2007/2/reumatizam-54-93.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1194.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1195.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/programme-eighth-annual-congress-of-the-croatian-society-for-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1196.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/osteoporosis-in-men/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1197.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/osteoporosis-treatment-with-alendronate-during-a-10-year-period/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1198.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/cyclic-use-of-pamidronate-in-osteoporosis-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1199.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/frequency-and-reasons-of-osteoporosis-therapy-termination-among-our-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1200.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/ultrasound-densitometry-of-the-heel-bone-in-patients-undergoing-chronic-hemodialysis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1201.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/relation-between-disease-activity-and-il-18-concentration-in-synovial-fluid-of-rheumatiod-arthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1202.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/expression-of-toll-like-receptors-in-peripheral-blood-cells-of-female-patients-with-systemic-lupus-erythematous/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1203.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/diagnosis-of-atherosclerotic-disease-in-patients-with-systemic-lupus-erythematous/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1204.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/antibody-profile-in-pregnant-women-with-antiphospholipid-syndrome-and-outcome-of-their-pregnancies-after-treatment-with-acetylsalicylic-acid-and-low-molecular-weight-heparin/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1205.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/clinical-and-radiographic-diagnostics-of-temporomandibular-disorders/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1206.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/osteoid-osteoma-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1207.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/disorders-of-the-locomotor-system-in-pregnancy-and-labor-and-their-elimination-by-applying-manual-medicine-techniques/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1208.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/physical-therapy-for-how-long-a-case-report-of-female-patient-with-ankylosing-spondylitis-and-sacroiliac-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1209.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/does-osteoporosis-influence-balance-study-of-balance-in-elderly-women/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1210.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/education-of-patients-with-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1211.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/osteoarthritis-of-temporomandibular-joint-in-patient-with-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1212.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/discrepancy-between-clinical-picture-and-densitometry-results-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1213.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/anticitrulline-antibodies-disease-activity-indicators-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1214.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/anticitrulline-antibodies-indicators-of-radiologic-changes-in-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1215.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/differential-diagnostics-between-polyarthritic-form-of-psoriatic-arthritis-and-rheumatoid-arthritis-in-women-using-quantitative-dermatoglyphic-analysis-of-digitopalmar-complex/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1216.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/radiologic-imaging-of-lipoma-arborescens/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1217.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/depression-in-patients-with-rheumatic-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1218.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/nephrotic-syndrome-in-systemic-visceral-lupus-with-secondary-antiphospholipid-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1219.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/whiplash-injury-problems-and-rehabilitation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1220.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/ultrasound-findings-in-patients-with-shoulder-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1221.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/low-back-pain-and-whole-body-vibration-syndrome/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1222.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/attitude-of-health-workers-towards-locomotory-system-preventive-measures/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1223.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/causes-of-early-stationary-rehabilitation-termination-in-patients-treated-at-the-department-for-physical-medicine-and-rehabilitation-in-bizovac/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1224.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/possibilities-and-role-of-ultrasound-in-diagnosing-intraosseous-tumors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1225.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/isokinetics-and-rehabilitation/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1226.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/analgesic-effect-of-tramal-retard-150-mg-in-patients-with-chronic-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1227.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/gaucher-disease-a-differential-diagnosis-in-paediatric-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1228.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/catastrophic-antiphospholipid-syndrome-in-a-boy-with-systemic-lupus-erythematosus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1229.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/osteoporosis-in-patients-with-psoriatic-arthritis-pilot-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1230.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/zaldiar-role-in-treatment-of-chronic-musculoskeletal-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1231.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/transtec-tds-buprenorphine/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1232.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-1233.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-1234.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-1235.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/hla-b27-gene-polymorphism-evolution-distribution-and-association-with-spondyloartopathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/hematological-abnormalities-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-11.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/clinical-and-radiographic-characteristics-of-patients-with-osteoarthritis-of-knees/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-11.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/epidemiology-of-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-18.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/terapeutic-ultrasound-in-chronic-low-back-pain-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-18.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/nsaid-prescription-in-patients-with-rheumatoid-arthritis-and-cardiovascular-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-22.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/vasculitis-in-rheumatoid-arthrtis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-25.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/initial-treatment-of-temporomandibular-joint-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-29.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/pathophysiology-of-postmenopausal-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-32.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/1/late-diagnosis-of-intraarticular-osteoid-osteoma-treated-as-hip-osteoarthritis-case-report-and-review-of-the-literature/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/1/reumatizam-53-33.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/imaging-of-metabolic-bone-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-36.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/nonpharmacological-treatment-of-osteoporosis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-40.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/why-are-collagenoses-dangerous-for-pregnancy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-51.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/pharmacotherapy-in-pregnancy-and-lactation-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-55.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/oxycodone-a-strong-opioid-in-the-treatment-of-patients-with-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-59.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/current-osteoporosis-treatment-reasons-for-adding-vitamin-d-to-alendronate/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-63.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/treatment-of-osteoporosis-by-risedronate-speed-efficacy-and-safety/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-66.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/ibandronate/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-72.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/teriparatide-new-value-in-osteoporosis-treatment-treatment-guidelines/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-77.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/the-role-of-nonopioid-analgetics-nonsteroidal-anti-inflammatory-drugs-and-weak-opioids-in-the-tretament-of-low-back-pain/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-82.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/appliance-of-viscosuplementation-in-ostheoarthritis-treatement/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-91.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2006/2/viscosuplementation-with-hyaluronic-acid-in-osteoarthritis-treatment-our-experiences/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2006/2/reumatizam-53-95.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/raloxifene-evista-in-the-treatment-of-postmenopausal-osteoporosis-the-profile-of-the-patient/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-638.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1236.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1237.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/programme-seventh-annual-congress-of-the-croatian-society-for-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1238.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/the-relation-of-body-weight-and-the-level-of-radiological-changes-in-patients-with-knee-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1239.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/rehabilitation-and-radiology-after-chirurgical-treatment-of-hip-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1240.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/the-effectiveness-of-local-therapy-in-female-patients-with-knee-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1241.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/manual-medicine-an-inevitable-component-of-the-complex-treatment-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1242.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/the-effectiveness-of-durogesic-in-treatment-of-chronic-pain-in-degenerative-and-inflamatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1243.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/regulatory-t-cells-in-juvenile-idiopathic-arthritis-jia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1244.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/interleukin-18-as-a-mediator-of-systemic-juvenile-idiopathic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1245.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/diagnostic-value-of-anti-ccp-test-for-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1246.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/nsar-intake-in-rheumatoid-arthritis-patients-in-the-period-2003-2005/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1247.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/the-prevalence-of-osteoarthritic-radiologic-signs-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1248.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/magnetic-resonance-imaging-of-the-wrist-in-early-rheumatoid-arthritis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1249.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/nephropathy-during-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1250.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/the-analyisis-of-hospitalized-sle-patients-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1251.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/osteoporosis-in-sle-patients-prelimary-results/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1252.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/imunological-and-renal-parameters-in-patients-with-systemic-lupus-erythematosus-and-lupus-nephritis-prior-to-and-after-the-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1253.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/the-role-of-plasmapheresis-in-therapy-of-severe-lupus-nephritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1254.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/cryptococcal-meningitis-in-sle-patient-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1255.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/mixed-connective-tisue-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1256.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/quantitave-analysis-of-digitopalmar-dermatoglyphics-in-the-patients-with-sixth-jajic-subtype-psoriatic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1257.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/coincidence-of-ochronosis-and-polymyalgia-rheumatica-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1258.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/arthritis-in-skin-psoriasis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1259.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/adinamic-bone-disease/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1260.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/osteopenia-and-osteoporosis-as-a-public-health-problem-in-the-vukovar-sirmium-county/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1261.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/osteoprotegerin-and-standard-indicators-of-bone-remodeling-in-postmenopausal-osteoporosis-and-osteopenia-the-role-and-significance/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1262.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/osteoprotegerin-in-osteoporosis-treatment-the-changes-dynamics-of-bone-remodeling/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1263.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/pharmacokinetic-properties-of-calcium-citrate-calcium-carbonate-and-placebo/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1264.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/isokynetic-testing-in-kynesytherapy-efficacy-control/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1265.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/radon-in-balneology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1266.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-1267.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/1/reumatizam-52-1268.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/1/reumatizam-52-1269.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/1/concern-about-one-drug-or-entire-class-of-drugs/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/1/reumatizam-52-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/1/a-contribution-to-genetic-etiology-of-complex-regional-pain-syndrome-type-i-algodystropy-syndrome-based-on-quantitative-analysis-of-digitopalmar-dermatoglyphics-in-sixty-men/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/1/reumatizam-52-7.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/skin-changes-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-9.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/1/drb1-gens-distribution-in-croatian-arthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/1/reumatizam-52-12.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/1/quo-vadetis-coxibes/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/1/reumatizam-52-17.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/osteoarthritis-epidemiology-economics-and-quality-of-life/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-21.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/1/renovascular-hypertension-due-to-takayasu-arteritis-a-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/1/reumatizam-52-28.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/patophysiology-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-30.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/osteoarthritis-radiology-imaging/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-36.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/nonpharmacological-treatment-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-40.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/pharmacotherapy-of-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-47.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/surgical-treatment-of-the-knee-osteoarthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-52.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/kidney-in-inflammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-56.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/renal-lupus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-58.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2005/2/nonsteroidal-antirheumatics-and-the-kidney/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2005/2/reumatizam-52-61.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/the-hip-in-musculoskeletal-disorders-nonsurgical-management/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-656.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/bjelolasica-2004-symposium-on-osteoporosis-preliminary-conclusions/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-658.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1270.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1271.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/programme-sixth-annual-congress-of-the-croatian-society-for-rheumatology/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1272.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/osteoporosis-in-pateints-with-ankylosing-spondilitis-pilot-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1273.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/main-clinical-features-of-inpatients-with-spondyloarthropathy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1274.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/spondyloartropathies-essg-and-amor-criteria/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1275.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/sapho-syndrome-case-report-of-female-patient-treated-with-combined-pharmacotherapy-pamidronatom/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1276.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/spondylodiscitis-in-ankylosing-spondylitis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1277.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/ankylosing-spondylitis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1278.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/radiology-of-ankylosing-spondylitis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1279.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/infliximab-in-ankylosing-spondylitis-first-experiences/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1280.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/the-use-of-low-frequency-magnetic-field-in-treatment-of-ankylosing-spondylitis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1281.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/hip-osteoarthritis-and-muscle-imbalance/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1282.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/changes-on-the-hip-in-the-course-of-rheumathoid-arthritis-and-their-influence-on-functional-disabilitiy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1283.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/transient-hip-osteoporosis-in-gravidity-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1284.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/early-prognostic-factors-in-juvenile-idiopathic-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1285.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/juvenile-dermatomyositis-and-vasculitis-differential-diagnosis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1286.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/multiple-brain-abcesses-caused-by-nocardia-sp-in-a-boy-with-systemic-lupus-erythemathodes/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1287.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/epidemiology-of-croatian-sle-patients-according-to-acr-classification-criteria/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1288.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/sle-of-central-nervous-system/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1289.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/two-patients-from-the-island-hvar-with-systemic-sclerosis-and-lung-cancer-adenocarcinoma-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1290.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/the-etiology-of-erythema-nodosum-10-years-retrospective-study-of-outdoor-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1291.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/crohn-disease-and-otitis-as-the-initial-manifestations-of-granulomatosis-wegener/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1292.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/incidence-of-cardiovascular-and-cerebrovascular-diseases-in-patients-with-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1293.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/anticitrulin-antibodies-new-diagnostic-and-prognostic-criterion-for-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1294.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/real-life-treatment-approach-in-rheumatoid-arthritis-patients/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1295.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/cytokine-profil-and-its-influence-on-acr-index-in-rheumatoid-arthritis-patients-treated-with-infliksimab/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1296.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/the-influence-of-rehabilitation-on-the-movement-of-hand-joints-in-rheumathoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1297.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/the-comparison-of-complete-haq-and-das-and-shortened-mhaq-i-das28-measures-for-activity-control-of-rheumatoid-arthritis/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1298.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/sjogrens-syndrome-in-inflammatory-rheumatic-diseases-diagnostical-and-treatment-problem/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1299.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/coxibs-in-a-treatment-of-reumatic-disease-retrospective-study/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1300.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/osteoporosis-in-postmenopausal-women-with-diabetes-mellitus/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1301.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/ochronosis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1302.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/cerebrotendinous-xanthomatosis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1303.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/rehabilitation-after-hip-fracture-caused-by-an-injury/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1304.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/terme-nin-in-the-process-of-construction-the-possibilities-of-treatment-of-rheumatic-diseases-by-peloid-liman/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1305.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/index-of-authors/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-1306.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/1/contents/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/1/reumatizam-51-1307.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/1/impressum/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/1/reumatizam-51-1308.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/1/the-distribution-of-hla-alleles-class-i-and-class-ii-among-patientes-with-psoriatic-arthritis-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/1/reumatizam-51-5.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/epidemiologija-i-dijagnostika-primarnoga-sjogrenovog-sindroma/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-9.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/1/standardisation-proposal-for-monitoring-rheumatoid-arthritis-patients-in-croatia/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/1/reumatizam-51-12.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/classification-and-patogenesis-of-spondyloarthropathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-13.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/early-diagnosis-of-axial-spondyloarthropaties/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-16.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/extraskeletal-manifestations-of-seronegative-spondyloarthropathie/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-19.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/1/primary-sjogrens-syndrome-and-hypokalaemic-paralysis-case-report/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/1/reumatizam-51-19.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/pharmacotherapy-for-spondiloarthropathies/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-22.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/1/weekly-and-daily-intake-of-alendronate-comparation-of-tolerance-in-osteoporosis-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/1/reumatizam-51-23.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/spondyloarthropathies-clinical-evaluation-and-physical-therapy/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-29.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/hip-in-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-34.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/hip-in-inlammatory-rheumatic-diseases/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-36.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/imaging-methodes-of-examining-the-hip-joint/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-39.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/articles/2004/2/compression-vertebral-fracture-in-osteoporosis-prevention-and-treatment/ 2026-07-17 monthly 0.8 https://www.reumatizam.abol.hr/media/journals/reumatizam/pdf/2004/2/reumatizam-51-43.pdf 2026-07-17 yearly 0.5 https://www.reumatizam.abol.hr/authors/1/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/2/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/3/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/4/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/5/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/6/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/7/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/9/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/10/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/11/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/12/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/13/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/15/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/16/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/17/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/18/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/19/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/20/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/21/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/22/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/23/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/25/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/26/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/27/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/28/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/29/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/30/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/31/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/32/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/33/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/34/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/37/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/38/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/40/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/41/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/42/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/43/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/44/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/45/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/46/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/47/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/48/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/49/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/50/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/51/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/52/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/53/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/56/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/57/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/58/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/60/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/61/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/62/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/63/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/64/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/65/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/66/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/67/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/68/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/69/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/71/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/72/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/73/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/74/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/75/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/76/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/77/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/78/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/79/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/80/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/81/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/82/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/83/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/84/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/85/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/86/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/87/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/88/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/89/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/90/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/92/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/93/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/94/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/95/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/96/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/97/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/98/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/99/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/100/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/101/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/103/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/104/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/106/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/107/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/108/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/109/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/110/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/111/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/112/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/113/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/114/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/115/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/116/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/117/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/118/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/119/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/120/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/121/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/122/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/123/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/124/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/125/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/126/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/127/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/128/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/130/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/131/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/132/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/133/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/134/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/135/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/136/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/137/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/138/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/139/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/140/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/141/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/142/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/143/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/144/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/145/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/146/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/147/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/148/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/149/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/150/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/151/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/152/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/153/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/154/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/155/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/156/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/157/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/158/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/159/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/160/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/161/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/162/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/163/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/164/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/165/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/166/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/167/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/168/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/169/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/170/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/171/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/172/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/173/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/174/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/175/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/176/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/177/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/178/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/179/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/180/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/181/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/182/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/183/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/184/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/185/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/186/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/187/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/188/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/189/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/190/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/191/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/192/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/193/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/194/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/195/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/196/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/197/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/198/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/199/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/200/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/201/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/202/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/203/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/206/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/207/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/208/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/209/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/210/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/211/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/212/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/213/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/214/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/215/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/216/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/217/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/218/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/219/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/220/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/221/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/222/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/224/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/225/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/226/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/227/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/228/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/229/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/230/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/231/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/232/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/233/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/234/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/235/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/236/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/237/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/239/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/240/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/241/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/242/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/243/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/244/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/245/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/247/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/248/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/249/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/250/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/251/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/252/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/253/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/254/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/255/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/256/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/257/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/258/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/259/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/260/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/261/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/262/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/263/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/264/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/265/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/266/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/267/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/268/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/269/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/270/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/271/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/272/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/273/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/274/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/275/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/276/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/277/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/278/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/279/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/280/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/281/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/282/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/283/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/284/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/285/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/286/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/287/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/288/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/289/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/290/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/291/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/292/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/293/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/294/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/295/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/296/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/297/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/299/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/300/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/301/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/302/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/303/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/304/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/305/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/309/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/310/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/312/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/313/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/314/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/315/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/316/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/317/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/318/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/319/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/320/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/321/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/322/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/323/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/325/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/326/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/327/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/328/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/329/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/330/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/331/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/332/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/333/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/335/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/336/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/337/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/338/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/339/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/341/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/342/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/343/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/344/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/345/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/346/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/347/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/348/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/349/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/350/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/351/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/352/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/353/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/354/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/355/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/356/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/357/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/358/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/359/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/361/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/362/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/363/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/364/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/365/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/366/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/371/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/383/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/384/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/385/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/386/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/387/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/388/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/389/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/390/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/391/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/392/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/393/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/394/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/395/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/396/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/397/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/398/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/399/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/400/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/401/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/402/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/403/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/405/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/406/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/407/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/408/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/409/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/410/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/413/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/414/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/415/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/416/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/417/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/418/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/419/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/420/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/421/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/422/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/423/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/424/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/425/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/426/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/427/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/428/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/429/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/430/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/431/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/432/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/433/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/434/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/435/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/437/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/438/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/439/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/440/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/441/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/442/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/443/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/444/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/445/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/446/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/447/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/448/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/450/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/451/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/452/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/453/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/454/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/455/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/456/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/457/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/458/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/459/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/460/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/461/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/462/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/463/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/464/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/465/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/466/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/467/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/468/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/469/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/470/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/471/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/472/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/473/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/474/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/475/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/476/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/477/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/478/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/479/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/480/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/481/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/482/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/483/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/484/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/485/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/486/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/487/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/488/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/489/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/490/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/491/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/492/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/493/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/494/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/495/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/496/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/499/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/500/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/501/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/502/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/503/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/504/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/505/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/506/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/507/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/508/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/509/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/510/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/511/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/512/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/513/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/514/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/515/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/516/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/517/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/518/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/519/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/520/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/521/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/522/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/523/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/524/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/526/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/527/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/528/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/529/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/530/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/531/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/532/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/533/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/534/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/535/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/536/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/537/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/538/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/540/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/541/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/542/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/543/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/544/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/545/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/546/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/547/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/548/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/549/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/550/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/551/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/552/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/553/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/554/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/555/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/556/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/557/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/558/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/559/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/560/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/561/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/562/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/563/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/564/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/565/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/566/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/567/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/568/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/569/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/570/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/571/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/572/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/573/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/574/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/575/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/576/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/577/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/578/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/579/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/580/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/582/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/583/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/584/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/585/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/586/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/587/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/588/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/589/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/590/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/591/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/592/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/593/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/594/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/595/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/596/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/597/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/598/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/599/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/601/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/602/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/603/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/604/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/605/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/606/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/607/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/608/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/609/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/610/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/611/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/612/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/613/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/614/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/615/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/616/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/617/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/618/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/619/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/620/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/621/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/622/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/623/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/624/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/625/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/626/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/627/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/628/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/629/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/630/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/631/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/632/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/633/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/634/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/635/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/636/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/637/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/638/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/639/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/640/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/641/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/642/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/643/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/644/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/645/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/646/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/647/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/648/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/649/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/650/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/651/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/656/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/657/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/658/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/659/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/660/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/661/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/662/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/663/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/664/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/665/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/666/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/667/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/668/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/669/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/671/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/674/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/675/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/676/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/677/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/678/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/679/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/680/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/683/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/685/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/686/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/687/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/688/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/691/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/692/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/695/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/696/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/698/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/701/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/702/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/703/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/704/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/705/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/706/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/707/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/708/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/709/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/710/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/711/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/718/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/719/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/721/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/723/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/730/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/731/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/732/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/733/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/734/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/735/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/736/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/737/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/740/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/741/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/743/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/744/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/749/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/752/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/756/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/758/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/760/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/762/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/763/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/765/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/769/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/778/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/779/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/780/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/781/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/782/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/783/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/786/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/787/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/788/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/790/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/795/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/799/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/800/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/801/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/806/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/809/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/811/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/812/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/813/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/814/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/815/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/816/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/817/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/818/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/819/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/821/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/822/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/823/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/824/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/825/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/826/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/827/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/828/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/829/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/830/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/831/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/832/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/833/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/834/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/835/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/836/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/837/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/838/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/839/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/840/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/841/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/842/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/843/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/844/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/845/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/846/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/847/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/848/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/849/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/850/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/851/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/852/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/853/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/854/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/855/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/857/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/858/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/859/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/860/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/861/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/862/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/863/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/864/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/865/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/866/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/867/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/868/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/869/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/870/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/872/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/873/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/874/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/875/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/876/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/877/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/878/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/879/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/880/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/881/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/882/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/883/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/885/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/886/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/887/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/888/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/889/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/890/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/891/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/892/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/893/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/895/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/896/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/897/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/898/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/899/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/900/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/901/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/902/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/903/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/905/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/906/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/907/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/908/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/909/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/910/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/911/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/912/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/913/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/914/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/915/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/916/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/917/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/918/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/919/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/920/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/921/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/922/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/923/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/924/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/925/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/926/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/927/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/928/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/929/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/930/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/931/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/932/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/933/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/934/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/935/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/936/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/937/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/938/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/939/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/940/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/941/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/942/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/943/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/944/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/945/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/946/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/947/ 2026-07-16 monthly 0.4 https://www.reumatizam.abol.hr/authors/961/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/962/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/963/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/964/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/971/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/972/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/973/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/976/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/977/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/978/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/979/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/980/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/981/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/982/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/983/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/984/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/985/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/991/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/992/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/993/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/994/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/995/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/996/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/997/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/998/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/999/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1000/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1001/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1002/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1003/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1004/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1005/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1006/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1007/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1008/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1009/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1010/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1011/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1012/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1013/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1014/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1015/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1016/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1017/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1018/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1019/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1020/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1021/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1022/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1023/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1024/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1025/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1026/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1027/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1028/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1029/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1031/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1032/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1033/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1034/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1035/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1036/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1037/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1038/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1039/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1040/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1041/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1042/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1043/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1044/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1045/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1046/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1047/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1048/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1049/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1050/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1051/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1052/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1053/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1054/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1055/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1056/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1057/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1058/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1059/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1060/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1061/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1062/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1063/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1064/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1065/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1067/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1068/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1069/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1070/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1071/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1072/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1073/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1074/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1075/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1076/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1077/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1078/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1079/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1080/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1081/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1082/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1083/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1085/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1086/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1087/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1089/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1092/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1093/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1094/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1095/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1096/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1097/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1098/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1099/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1100/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1101/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1102/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1103/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1104/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1105/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1106/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1107/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1108/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1109/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1110/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1111/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1112/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1113/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1114/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1115/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1116/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1117/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1118/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1119/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1120/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1121/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1122/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1123/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1124/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1125/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1126/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1127/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1128/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1129/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1130/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1131/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1132/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1133/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1134/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1135/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1136/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1137/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1138/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1139/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1140/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1141/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1142/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1143/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1144/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1145/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1146/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1147/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1148/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1149/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1150/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1151/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1152/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1153/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1154/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1155/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1156/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1157/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1158/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1159/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1160/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1161/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1162/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1163/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1164/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1165/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1166/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1167/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1168/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1169/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1170/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1171/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1172/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1173/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1174/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1175/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1176/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1177/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1178/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1179/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1180/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1181/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1182/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1183/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1184/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1185/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1186/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1187/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1188/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1189/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1190/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1191/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1192/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1193/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1194/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1195/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1196/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1197/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1199/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1201/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1202/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1204/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1205/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1206/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1207/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1208/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1209/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1210/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1211/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1212/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1213/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1215/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1216/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1219/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1220/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1221/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1222/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1223/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1224/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1225/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1226/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1227/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1228/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1229/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1230/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1231/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1232/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1233/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1234/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1235/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1236/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1237/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1238/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1239/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1240/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1241/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1242/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1243/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1244/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1245/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1246/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1247/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1248/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1249/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1250/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1251/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1252/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1253/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1254/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1255/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1256/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1257/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1258/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1259/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1260/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1261/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1262/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1263/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1264/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1265/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1266/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1267/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1268/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1269/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1270/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1271/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1272/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1273/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1274/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1275/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1277/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1278/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1279/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1280/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1281/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1282/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1283/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1284/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1285/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1286/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1287/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1288/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1289/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1290/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1291/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1292/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1293/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1294/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1295/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1296/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1297/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1298/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1299/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1300/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1301/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1302/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1303/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1304/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1305/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1306/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1307/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1308/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1309/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1310/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1311/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1312/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1313/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1314/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1315/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1316/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1317/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1318/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1320/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1324/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1325/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1326/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1327/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1328/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1329/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1330/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1331/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1332/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1333/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1334/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1335/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1336/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1337/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1338/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1339/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1340/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1341/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1342/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1343/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1344/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1345/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1346/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1347/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1348/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1349/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1350/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1351/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1352/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1353/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1354/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1355/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1356/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1357/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1358/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1359/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1360/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1361/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1362/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1363/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1364/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1365/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1366/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1367/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1368/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1369/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1370/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1371/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1372/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1373/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1374/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1375/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1376/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1377/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1378/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1379/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1380/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1381/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1382/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1383/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1384/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1385/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1387/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1388/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1389/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1390/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1392/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1394/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1397/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1398/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1399/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1400/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1401/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1402/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1403/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1404/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1405/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1406/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1407/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1408/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1409/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1410/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1411/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1412/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1413/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1414/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1415/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1416/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1417/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1418/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1419/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1420/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1421/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1422/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1423/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1424/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1425/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1426/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1427/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1428/ 2026-07-17 monthly 0.4 https://www.reumatizam.abol.hr/authors/1429/ 2026-07-17 monthly 0.4